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Overview 
This volume consists of three parts. 
Part 1, the literature review, examines 20 papers to describe the current 
understanding of the relationship between therapist alliance, therapist adherence and 
outcome in individual psychotherapy. 
Part 2, the empirical paper, uses data from participants in the Positive 
Reinforcement targeting Abstinence In Substance misuse (PRAISe) randomised 
control trial being conducted in south east England. This trial investigates the 
effectiveness of contingency management (CM) interventions in opiate substitution 
therapy to improve attendance and abstinence of heroin. The paper explores the 
impact of CM interventions on levels of attendance in opiate substitution therapy and 
investigates the relationship between client factors, therapeutic alliance, therapist 
adherence to the CM and levels of attendance.  
Part 3, the critical appraisal, is in two sections. The first section explores the 
debate between research that attributes therapeutic outcome to factors that are 
common across different types of psychotherapy such as the therapeutic alliance, and 
research that highlights the importance of the contribution of theory specific 
interventions, measured by therapist adherence. The second section considers some 
of the moral and ethical concerns about using incentives in health care and some of 
the implications for future research and clinical practice. 
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Part 1: Literature Review 
 
Is there a relationship between therapeutic alliance, therapist 
adherence, and outcome in individual psychological therapy? 
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Abstract 
Aims   Therapeutic alliance has been found to have an association with 
outcome in psychotherapy, and concern has been expressed that therapist adherence 
to manualised treatment can impact negatively on the therapeutic alliance. The 
purpose of this review is to report on the current understanding of the relationship 
between therapeutic alliance, therapist adherence and outcome in individual 
psychotherapy. 
Methods  A literature search aimed at identifying studies that included 
quantitative measures of therapeutic alliance and therapist adherence in individual 
psychotherapy was conducted.  
Results  20 papers were identified to be included in the review reflecting the 
limited amount of literature that considers the relationship between adherence and 
alliance. Included papers focused on a range of therapies and clinical presentations.  
Conclusion  This review suggests that adherence does not have a detrimental 
effect on alliance. Furthermore, most studies do not find an interaction between 
adherence and alliance in predicting outcome. Some studies report a relationship 
between curvilinear adherence and alliance in predicting outcome. The few studies 
that consider this relationship indicate that in the context of low alliance, moderate 
adherence is best for outcome. It is suggested that this reflects therapists using 
intervention to support the therapeutic alliance whilst remaining largely consistent 
with the therapeutic model. Therapy models should therefore include strategies to 
help foster the therapeutic alliance. It is noted that the conclusions made in this 
review are limited by the small number of studies that consider the relationship 
between adherence, alliance and outcome and the individual study limitations.  
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Introduction 
The aim of this review is to describe the existing understanding of the 
relationship between therapist adherence, therapeutic alliance and outcome. The 
rationale for this is based on findings of a relationship between alliance and outcome, 
(e.g. Horvath, Del Re, Fluckiger, & Symonds, 2011) and concern that therapist 
adherence can have a negative effect on alliance (e.g. Addis, Wade, & Hatgis, 1999). 
This introduction considers psychotherapy process research that fuels the interest 
into ‘common factors’ and the therapeutic alliance. The current understanding of the 
relationships between alliance and outcome, and adherence and outcome are 
summarised. Studies that have specifically considered the relationship between 
adherence, alliance and outcome are highlighted. 
Equivalent outcomes across psychotherapies  
Investigations into the effect of factors such as the therapeutic alliance and 
therapist adherence stem from studies that find equivalent outcomes when comparing 
psychotherapies (e.g. Luborsky Rosenthal, Diguer, Andrusyna, Bermin Levitt et al., 
2002; Luborky, Singer & Luborsky, 1975), raising the question of what is the 
mechanism of change in psychotherapy. Messer and Wampold (2002) states that 
‘study after study, meta-analysis after meta-analysis have produced small or non-
existent differences among therapies’ (pp.22) which indicates that there are pervasive 
common factors across psychotherapies that result in the equivalence of outcome 
when comparing psychotherapies (Rosenzweig , 1936, as cited in Luborsky et al., 
1975).  Many supporters of this common factors perspective believe the therapeutic 
alliance is the mechanism of change in therapy (McCarthy, 2009).  
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Therapeutic alliance 
One of the most frequently and extensively studied common factors is the 
therapeutic alliance (Castonguay, Constantino, & Holtforth, 2006) but there remains 
ambiguity in the definition of it (Horvath et al., 2011). A commonly cited definition 
of alliance is proposed by Bordin (1979). Bordin (1979) concept of alliance is based 
on achieving a collaborative stance in psychotherapy. This alliance is based on three 
components; goals, tasks and bond. Goals refer to the client and therapist agreeing 
on what the client hopes to gain from therapy. Tasks refers to agreement on what 
needs to be done to reach the client’s goals. Bond refers to the trust and attachment 
that develops between a therapist and client. 
Horvath et al. (2011) conducted a meta-analysis of studies that investigated 
the relationship between therapeutic alliance and the outcomes in individual 
psychotherapy. The authors report a small but significant aggregate effect size1, with 
no indication of publication bias and no significant relationship with time of 
publication.  This result is similar to previous analyses (Horvath & Symonds, 1991; 
Martin. Garske, & Davis, 2000; Horvath & Bedi, 2002).  
Therapist Adherence 
Critics of the common factors perspective argue that findings of equivalence 
do not imply that the same mechanisms produce the outcome (DeRubeis, Brotman, 
& Gibbons, 2005) and instead work through interventions specific to a theoretical 
orientation (McCarthy, 2009). There is therefore an interest in the extent to which a 
therapist is delivering theory specific techniques. 
                                                 
1 Throughout this review interpretation of effect size is informed by Cohen (1998) .10 are considered 
small,.30 are moderate, and.50 are large. 
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Adherence is defined as the degree to which therapists are delivering the 
specified techniques of an intervention (Webb, DeRubeis & Barber, 2010). 
Adherence measures are often employed in psychotherapy research to ensure a 
treatment is delivered as intended (Weck, Weigel, Richtberg, & Stangier, 2011) and 
to further understanding of which elements of an intervention contribute to outcome 
(Webb et al., 2010). Treatment research increasingly involves the use of manual 
based treatments (Godley, White, Diamond, & Passetti, 2001) which are strategic 
and technical guidelines for the therapist to follow in conducting therapy. 
There is an interesting distinction here between adherence as a common 
factor across different types of therapy, and the ‘specific factors’ of a particular 
treatment that are being considered by the measure of adherence.  Adherence may 
contribute to outcome not by virtue of the specific technique being measured, but as 
a variable regardless of which technique is being measured i.e. as a common factor. 
Therapists adhering strictly to a manual, having low adherence or using techniques 
flexibly may have differential effects on outcome regardless of the treatment type 
being employed.  Indeed critics of manualised treatments arguing that rigid 
adherence can have a detrimental effect on the therapeutic alliance discuss adherence 
in general terms, as though it is a common factor.  
Generally adherence-outcome studies have reported mixed findings (Webb et 
al., 2012a). A recent meta-analysis (Webb et al., 2010) reported non-significant 
effect sizes for adherence-outcome  relationships. However the heterogeneity of 
effect sizes across studies, and therefore mean effect sizes should be interpreted with 
caution. It may be that adherence is related to outcome only in some contexts or 
treatment modalities (Webb etal.  2012a). Some studies have reported a curvilinear 
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relationship between adherence and outcome (Hogue et al., 2008a; Barber et al., 
2006)  indicating that modest levels of adherence are associated with best outcome.  
The Adherence-Alliance relationship 
Some authors report concern about a possibility of a negative effect of 
therapist adherence to manual based treatment on the therapeutic alliance (Wilson, 
1998). Addis et al. (1999) state that it is a common concern that it is not possible to 
develop an effective alliance while using manualised treatments. Although, as 
Wilson (1996) emphasises, ‘far from undermining therapist’s personal expertise in 
conducting treatment, manual based therapies require specific skills in developing 
effective therapeutic alliances with patients’ (pp. 11).  
There is little research focusing on the relationship between adherence, 
alliance and outcome. Some authors report a negative association between adherence 
and alliance (Henry, Strupp, Butler, Schacht, & Binder, 1993a; Henry, Strupp, 
Butler, Schacht, & Binder, 1993b). Other research suggests a more complicated 
relationship between adherence, alliance and outcome. For example Barber et al. 
(2006) found a moderating effect of alliance on the relationship between adherence 
and outcome. When alliance was high, adherence was largely irrelevant to outcome. 
However, when alliance was weaker, moderate levels of adherence were most 
beneficial for outcome. 
Aims 
Given the reported relationships between alliance, adherence and outcome, 
and concerns about a negative effect of adherence on alliance this review endeavours 
to capture the existing understanding of the relationship between these variables. 
Specifically, whether alliance and adherence have a negative association and whether 
the interaction between adherence and alliance impacts on outcome. 
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Method 
Literature search strategy 
A systematic search of the literature was conducted using PsycINFO, 
MEDLINE and PUBMED computerised databases. A slightly different search 
strategy was used for each database due to their different organisation, features, 
thesaurus and subject headings. 
Scoping searches indicated little literature specifically researching the 
relationship between adherence or competence and alliance. Indeed, conducting a 
meta-analysis on 36 papers investigating the relationship between adherence and 
outcome Webb et al. (2010) identified only 11 papers that controlled for therapeutic 
alliance. Therefore a deliberately broad search strategy was employed in order to 
capture as many relevant papers as possible.  
Searching PsycInfo used combinations of the keywords; Alliance, fidelity, 
competence2 and adherence. In addition the following terms mapped to subject 
headings were used: manual based therapy3, competence, and therapist competence. 
The following terms were exploded; therapeutic alliance, competence, professional 
competence. 
Searching MEDLINE used combinations of the following words mapped to 
subject headings; professional-patient relations, alliance, guideline adherence, 
adherence, therapist competence, professional competence, manual based therapy. 
Searching PUBMED used combinations of the following words: alliance, 
adherence, fidelity, therapist competence, and manual based therapy. 
                                                 
2 Competence was included in the search term as there was an indication that the terms may be used 
interchangeably in the literature. 
3 The following search terms were used to identify papers relevant to manual based therapy in all 
databases: manual based therap*. manual guided therap* manuali?ed therap*. 
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These searches identified 4689 studies for consideration for the review. 11 
additional studies were found through hand searching and reference lists. From these 
studies 20 were included in the review (meeting the criteria below). Figure 1 shows 
the results from the search and study selection. 
Paper inclusion criteria 
Informed by previous reviews of studies investigating alliance-outcome 
(Martin et al., 2000; Horvath et al., 2011) and adherence outcome relationships 
(Webb et al. 2010), the following criteria were used. 
1) Clinical population 
2) An investigation of individual psychological treatment 
3) Quantifiable measures of alliance and adherence 
4) Data relevant to the research question. Specifically: 
i. Correlational data of adherence- alliance, or 
ii. Analyses predicting alliance from adherence or vice      
versa, or 
iii. Analyses predicting outcome from adherence and    
alliance, presenting interaction data. 
Quality assessment 
No formal measure of quality was used. The Cochrane collaboration (Higgins 
& Green, 2011) warns against using scales or checklists instead recommending a 
domain based evaluation. The Cochrane collaboration’s tool for assessing risk of bias 
is better suited to assessing the quality of randomised clinical control trials. This 
review is focused on the particular relationship between alliance, adherence and 
outcome, and involves extracting data from different study designs. As such 
particular attention is given to the sample size, the aspects of adherence and alliance 
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that are being measured, the expertise and independence of the raters assessing 
adherence and alliance, the inter-rater reliability where more than one rater is used, 
the timing of the assessment of adherence alliance and outcome in relation to each 
other, and the validity of diagnosis and outcome measurement. 
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Figure 1: Flow diagram of search and study selection 
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11 
 
Results 
In order to address the aims of the review the results of the identified studies 
are presented and summarised using narrative synthesis (Popay et al., 2006). 
Narrative synthesis takes a textual approach in synthesising the results to tell a story. 
First studies focussing on depression are considered followed by studies focused on 
substance use disorders and those considering other clinical presentations. A 
summary table of significant statistics can be found in Table 1. 
Studies focusing on depression 
Eight studies were identified that focused on depression (Table 2). Various 
criteria were used to assess depression and all appear valid. For example, using a 
structured clinical interview to establish a DSM diagnosis (Bambling, King, Raue, 
Schweitzer & Lambert, 2006) or meeting Research Diagnostic Criteria (e.g. 
Castonguay, Goldfried, Wiser, Raueand & Haye,1996), or identifying clinical 
caseness using a clinical cut off on a validated self-report instrument such as the 
Beck Depression Inventory (BDI) (Minonne, 2008).Where presented inter-rater 
reliability coefficients were adequate, ranging  from moderate to perfect agreement 
(Appendix A). 
 Treatment of Depression Collaborative Research Program (TDCRP): Three 
studies used data from the TDCRP. Strunk, Brotman & DeRubeis (2010) considered  
the relationship between adherence to cognitive therapy and alliance within each of 
the first four sessions. The authors report several moderate correlations between 
different aspects of cognitive therapy and alliance and no interaction between 
adherence and alliance in predicting outcome. 
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Table 1 
 
Results summary table 
 
 
Study Title 
 
Test 
 
Result 
 
 
Studies focusing on depression 
 
Strunk et al. (2010) Correlation (r) alliance and adherence  
Alliance and Cognitive Methods  
Alliance and Negotiating/Structuring;  
Alliance and Behavioural Methods Homework  
Adherence X Alliance interaction in predicting outcome 
 
 
r = 0.36, p < .05 
r =.48, p < .05 
r = 0.29, p< .05 
no significant interaction 
 
Webb  et al. (2012b) Correlations (r) alliance and adherence  
Alliance and Cognitive therapy (Concrete Factor)  
Adherence X Alliance interaction in predicting outcome 
 
 
r = 43. p < .01 
No significant interaction 
Minonne (2008) Correlations (r) alliance and adherence  
Alliance and CBT,  
Alliance and IPT 
Adherence X Alliance interaction in predicting outcome 
 
 
No significant correlation 
r =.36 p= 0.005 
No analysis 
Castonguay et al. (1996) 
 
 
 
Correlations (r) alliance and adherence  
Alliance and CT technique 
Adherence X Alliance interaction in predicting outcome 
 
 
No significant correlation 
No analysis 
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Strunk et al. (2012) Correlations (r) alliance and adherence  
Alliance and Cognitive Methods  
Alliance and Negotiating/Structuring  
Alliance and Behavioural Methods Homework:  
Adherence X Alliance interaction in predicting outcome 
 
r = 0.21, p< .05 
r = 0.24, p < .05 
No significant correlation 
No significant interaction 
 
Gaston and Ring (1992) Correlations (r) alliance and adherence  
Whole sample  
Improved patients: alliance and exploratory strategies 
 Non-Improved patients: alliance and exploratory Strategies  
Adherence X Alliance interaction in predicting outcome 
 
 
No significant correlations  
r = 0.65, p < 0.01 
r = 0.30, p> 0.05 
No analysis 
Gaston et al. (1998) Correlations (r) alliance and adherence  
Patient working capacity and explorative strategies  
Patient working capacity and supportive strategies 
Other scales of CALPAS-R and adherence 
Adherence X Alliance interaction in predicting outcome 
BT Sample 
Patient working capacity and explorative strategies 
CT Sample 
Patient working capacity and explorative strategies 
BDT Sample 
Patient working capacity and explorative strategies 
 
 
r =.36 (stated to be ‘significant) 
r = -.29 (stated to be ‘significant’) 
No significant Correlations 
 
 
R2= 10, p < .05 
 
CT R2 = 15, p < .05 
 
No significant interaction 
Bambling et al. (2006) 
 
 
 
 
Correlations (r) alliance and adherence  
Alliance and problems Solving therapy  
Adherence X Alliance interaction in predicting outcome 
 
 
No significant correlations 
No analysis 
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Studies focusing on substance misuse 
 
Carroll et al. (1997) 
 
Correlations (r) alliance and adherence  
Alliance and CBT  
Adherence X Alliance interaction in predicting outcome 
 
 
r =  .41, p < .01 
No analysis 
Hogue et al. (2008b) 
 
 
 
Correlations (r) alliance and adherence  
Alliance and:CBT  
Alliance and MDFT-  
Adherence X Alliance interaction in predicting outcome 
 
 
r = .28, p < 0.05 
no significant correlation 
No analysis 
Gibbons et al.(2010) Correlations (r) alliance and adherence  
Adherence X Alliance interaction in predicting outcome 
General Linear Model 
Linear adherence 2 session MET X alliance- 
Linear adherence 9 session MET/CBT/CM X alliance 
Curvilinear adherence 2 session MET X alliance 
Curvilinear adherence 9 session MET/CBT/CM X alliance  
 
No analysis 
 
no significant interaction 
no significant interaction 
No significant interaction 
t = 2.77, p = 0.01 
 
Barber et al. (2008)  Correlations (r) alliance and adherence  
Adherence X Alliance interaction in predicting outcome 
Mixed model ANOVA 
Curvilinear adherence SET X CALPAS at session 2  
Curvilinear adherence SET X HAQ at session 2 
Curvilinear adherence SET X CALPAS at session 5  
Curvilinear adherence SET X HAQ at session 5 
Curvilinear adherence Expressive subscale X CALPAS Session 2 
No significant correlations 
 
 
no significant interaction. 
F(1, 86) = 4.94, p < .03  
F(1.60) = 4.49, p < .04;  
F(1.69) = 4.79, p < .04 
F(1,86)= 5.17, p <.03;  
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 Curvilinear adherence Expressive subscale X HAQ Session 2 
Curvilinear adherence Supportive subscale X CALPAS Session 2 
 
F(1.86) = 7.73, p < .007 
No significant interaction 
  
 Curvilinear adherence Supportive subscale X HAQ Session 2 
Curvilinear adherence Expressive subscale X CALPAS Session 5 
Curvilinear adherence Expressive subscale X HAQ Session 5 
Curvilinear adherence Supportive subscale X CALPAS Session 5 
Curvilinear adherence Supportive subscale X HAQ Session 5 
No significant interaction 
F (1, 69) = 8.08, p < 0.006 
F (1.69)= 3.81, p <. .06 
No significant interaction 
No significant interaction 
 
Barber et al. (2006) Correlations (r) alliance and adherence  
Adherence X Alliance interaction in predicting outcome 
Mixed model ANOVA 
Linear adherence IDC X alliance- no significant interaction 
Curvilinear adherence IDC X CALPAS at session 2: 
Curvilinear adherence IDC X HAQ at session 2: 
Curvilinear adherence IDC X CALPAS at session 5: 
Curvilinear adherence IDC X HAQ at session 5: 
 
 
No analysis 
 
 
no significant interaction 
F(1, 82) = 5.06, p < 0.03 
F(1, 82) = 3.98, p = .05. 
F(1, 53) = 4.04, p <.05 
F(1 , 53) = 5.90, p < .02 
 
Studies focusing on other clinical presentations 
  
 
 
Evans-Jones et al. (2009) Correlations (r) alliance and adherence  
Alliance and CBT  
Adherence X Alliance interaction in predicting outcome  
 
r =.468, p = .02 (a trend p<.01 used) 
NA 
 
Goldman and Gregory 
(2009) 
 
Correlations (r) alliance and adherence  
Alliance and DDP  
Adherence X Alliance interaction in predicting outcome 
 
No significant correlation 
No analysis 
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Ogrodniczuk, and Piper 
(1999) 
 
 
 
 
 
Correlations (r) alliance and adherence  
Alliance and interpretive therapy: 
Interpretive therapy sample 
Whole sample 
Alliance and supportive therapy  
Supportive therapy sample  
Whole sample  
 
 
 
r = 0.23, p < .05 
r = 0.21, p < .05 
 
r = 0.36, p < .05 
r = 0.18, p < .05 
Gaston et al.(1994) Correlations (r) alliance and adherence  
Patient working capacity and exploratory strategies  
Patient commitment Scale and exploratory strategies  
Patient working capacity and supportive strategies  
Patient Commitment and supportive strategies  
Adherence X Alliance interaction in predicting outcome 
Hierarchical multiple regression 
Long term psychotherapy sample 
Explorative Strategies X alliance predicting depression and anxiety  
Supportive Strategies X alliance predicting depression and anxiety  
Explorative Strategies X alliance predicting Interpersonal Behaviour 
Supportive Strategies X alliance predicting interpersonal behaviour  
 
 
r = 0.29 
r =.11 
r =.47 p <.01. 
r = -.25 
 
 
 
R2= .25, p <.05 
R2=.16, p <.05 
R2= .30, p<.05 
R2=.17, p< .05 
Pavio et al. (2004) Correlations (r) alliance and adherence  
Alliance and EFT  
Adherence X Alliance interaction in predicting outcome 
 
 
r = 35, p ≤ .05 
No analysis 
Liber et al.(2010) 
 
 
Correlations (r) alliance and adherence  
Alliance and early CBT adherence  
Alliance and late CBT adherence. 
 
r =.44, p  < .05 
r =.45, p < .05 
17 
 
 
 
Adherence X Alliance interaction in predicting outcome No analysis 
Loeb et al. (2005) Correlations (r) alliance and adherence  
Patient factor and CBT at session 6 
Patient factor and CBT at session 12 
Patient factor and CBT at session 18 
Therapist factor and CBT at session 6 
Therapist factor and CBT at session 12 
Therapist factor and CBT at session 18 
Patient factor and IPT at session 6 
Patient factor and IPT at session 12 
Patient factor and IPT at session 18 
Therapist factor and IPT at session 6 
Therapist factor and IPT at session 12 
Therapist factor and IPT at session 18 
Adherence X Alliance interaction in predicting outcome 
 
 
r = .55, p < .01 
r = .51, p < .01 
r - .46, p < .01 
r = .63, p < .01 
r = .74, p < .01 
r = .65, p < .01 
r = .58, p < .01 
r = .39, p < .01 
r = .43, p < .01 
r = .65, p < .01 
r = .56, p < .01 
r = .64, p < .01 
No analysis 
CT= Cognitive Therapy, ADM= Anti-depressant Medication, CBT= Cognitive Behavioural Therapy, IPT= Interpersonal Therapy, BDT= Brief Dynamic Therapy, MDFT= 
Multi-Dimensional Family Therapy, MET= Motivational Enhancement Therapy, CM= Clinical Management, SET= Supportive Expressive Dynamic Therapy, EFT=Emotion 
Focused Therapy, DDP= Dynamic deconstructive psychotherapy, CALPAS= = California Psychotherapy Alliance Scales  HAQ= Helping Alliance Questionnaire,  
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Table 2 
 
Studies focusing on patients with depression 
 
 
Study Title 
 
Sample 
 
Therapy 
 
Primary Focus 
 
Adherence Measure  
 
Alliance measure  
 
Outcome 
Strunk et al. 
(2010) 
N=60 adults 
from CT Arm of  
TDCRP 
 
 
CT 
Sessions twice 
weekly for the 
first 4–12 
weeks 
and weekly 
thereafter 
 
Relationship 
between 
adherence and 
outcome 
3 scales from the CSPRS; 
Cognitive methods 
subscale; 
Negotiating/Structuring 
subscale Behavioural; 
Methods Subscale. 
Observer rated 
WAI 
Session to Session 
change on BDI 
Webb, et al. 
(2012b) 
N= 105 Adults 
from CT arm 
TDCRP and 
University of 
Washington 
Trial 
CT 
16 weeks 
Evaluating the 
relationship 
between 
adherence 
alliance and 
outcome 
CSPRS: CT-Concrete 
Factor-  active, symptom 
focused methods   
 
Observer rated 
WAI 
Post treatment BDI 
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Minonne (2008) N= 120 adults 
taken from 
TDCRP CBT 
(n=59) and IPT 
(n=61) 
conditions 
 
CBT 
IPT 
16 weeks 
Relationship 
between 
adherence, 
alliance and 
outcome 
 
CSPRS: CBT and IPT 
scales 
VTAS Post treatment BDI 
Castonguay et 
al.s (1996) 
N=30 Adults 
from CT 
condition of  
Cognitive-
Pharmacotherapy 
Project 
 
 
 
CT 
Average 15.4 
sessions 
Relationship 
between 
unique aspects 
of CT, 
alliance , 
patient 
involvement 
and outcome 
The Coding System of 
Therapist Feedback. 
Rating the cause and 
effect between two 
components of the 
patient’s functioning. 
Observer rated 
WAI 
Post treatment BDI 
and HDRS 
Strunk,et al. 
(2012) 
N= 176 adults 
from combined 
CT and ADM 
condition of a 
three-site, 
randomized trial  
 
CT + ADM Relationship 
between 
adherence, 
alliance 
outcome 
3 scales CSPRS: 
Cognitive methods 
subscale; 
Negotiating/Structuring 
subscale; Behavioural and 
Methods Subscale 
Observer rated 
WAI 
Session to session 
change on BDI 
Gaston and Ring 
(1992) 
N= 10 Older 
Adults from 
Brief Dynamic 
Therapy arm of. 
Brief Dynamic 
Therapy. 
16-20 session 
Assessing the 
qualities of 
adherence 
measure 
ITS CALPAS: Total 
Score; Therapist 
Understanding 
and  Involvement  
Post BDI and HDRS 
scores 
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 larger controlled 
clinical trial 
 
   Scale  
Gaston et al. 
(1998) 
N=91 Older 
adults from 
active treatment 
conditions of 
controlled 
clinical trial 
Behaviour 
Therapy, CT, 
Brief Dynamic 
Therapy  
 
16- 20 
sessions 
Relationship 
between 
alliance, 
therapy 
technique and 
outcome 
ITS CALPAS: Patient 
Working Capacity 
Scale;  Patient 
Commitment 
Scale; Working 
Strategy 
Consensus and  
Post treatment BDI 
and HDRS scores 
     Therapist 
Understanding 
scale 
 
 
Bambling, et al. 
(2006) 
N=127 Adults PST 
8 session 
Evaluating the 
impact of 
clinical 
supervision  
on working 
alliances and 
outcome 
 
PST adherence Scale 
completed by therapists 
self report and observer 
rated. 
Client rated WAI NA 
CT= Cognitive Therapy, TDCRP= Treatment of Depression Collaborative Research Program, ADM= Antidepressant Medication,  CSPRS =Collaborative Study 
Psychotherapy Rating Scale, WAI=Working Alliance Inventory,  BDI=Beck Depression Inventory, ITS= Inventory of Therapeutic Strategies, HDRS= Hamilton Depression 
Rating Scale, CALPAS=California Psychotherapy Alliance Scales, PST= Problem Solving Therapy, CBT= Cognitive Behavioural Therapy, IPT= Interpersonal Therapy, 
VTAS= Vanderbilt Therapeutic Alliance Scale,  MAPE=Manualised Active Psycho-Education, HAQ= Helping Alliance Questionnaire4 
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Strunk et al. (2010) study benefits from using established measures of 
alliance and adherence. Alliance, adherence and outcome are collected at the same 
session, and therefore, any relationship between the variables is unlikely to be due to 
processes that occur between their measurements (Webb et al., 2010). However no 
analysis is offered investigating how alliance and adherence may be related across 
the course of therapy.  Although raters were blind to outcome the same raters rated 
all process variables across all sessions. It is possible that raters’ hypotheses about 
the relationship between variables and knowledge of symptom change could have 
biased ratings. 
Webb, Dimidjian, Hollon, and Amsterdam (2012b) use data from the TDCRP 
and also from the University of Washington Study. This study reports a moderate 
relationship between symptom focused methods of cognitive therapy and alliance 
assessed at an early session of therapy. The authors found no interaction between 
adherence and alliance in predicting outcome. 
Webb et al.(2012b)  benefits from controlling for symptom change occurring 
before the measurement of adherence and alliance. Another strength is that authors 
present a power analysis demonstrating their sample size was sufficient. Adherence 
and alliance were used to predict outcome at the end of therapy. Therefore any 
relationship between the predictors and outcome could be overshadowed by other 
processes occurring between their measurements. The authors also note that, there 
may be a restriction in range of adherence and alliance limiting the ability to detect 
interactions.  
The studies above are informative about the relationship between alliance and 
adherence when collected at the same session. A recent doctoral dissertation 
(Minonne, 2008) provides information about the relationship between alliance and 
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adherence measured at different points in therapy. Minonne (2008) used data from 
the CBT and Interpersonal Therapy (IPT) conditions of the TDCRP.  In CBT, 
Minonne (2008) reports no significant relationships between alliance and adherence 
and a non-significant trend for early alliance to be associated with adherence. For 
IPT, early alliance was associated with later IPT adherence. These findings indicate 
that it may be important to consider the relationship between alliance and adherence 
across the course of therapy, and in relation to specific forms of therapy. 
Minonne (2008) benefits from using two raters per tape and only one session 
per patient was rated for adherence by each rater. This limits the possibility of prior 
knowledge of a particular patient’s, adherence, alliance, or symptomology from 
biasing ratings. However no information is provided as to inter rater reliability or 
rater expertise for alliance ratings. 
Studies using data from other sources: Castonguay et al. (1996) reports a 
non-significant correlation between adherence to specific CBT strategies and alliance 
collected during a single session of cognitive therapy. Descriptive analyses suggest 
that therapists increased their adherence to correct problems with therapeutic 
alliance, which worsens alliance strains. It is emphasised that the correlation between 
adherence and alliance is statistically non-significant and there was no significant 
interaction between alliance and adherence in predicting outcome. These findings 
indicate that it may be necessary to consider the relationship between alliance and 
adherence over time, in this case over the course of a session to understand how the 
two variables may be associated and interact. 
Castonguay et al. (1996) benefits from using multiple raters for each variable. 
This study also conducts analysis demonstrating that reported findings are not 
dependent on drop out pattern. Again adherence and alliance were  measured at the 
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same session so little can be known about the relationship between them over the 
course of therapy . Outcome was measured at the end of therapy and therefore any 
relationship between, or absence thereof, could be attributed to processes that occur 
between measurement of the predictor and outcome variables.  This study used 
adherence to a specific strategy and therefore findings may not be generalisable to 
other aspects of adherence. 
With the exception of Minonne (2008), the studies above provide information 
on the relationship between adherence and alliance when they are assessed at the 
same sessions. Strunk, Cooper, Ryan, DeRubeis and Hollon (2012) differ from the 
previous studies in that a mean rating of adherence and alliance from across the 
sessions is used.  The authors found significant small correlations between cognitive 
methods and alliance, and between Negotiating/Structuring and alliance but not 
between Methods/Homework and alliance. No interaction between alliance and 
adherence in predicting outcome was found.   Again this indicates that the 
adherence-alliance relationship may differ depending on what aspect of adherence is 
measured. 
Gaston and Ring (1992) use data from 10 patients in the brief dynamic 
therapy arm of a clinical trial using data collected at three sessions across the course 
of therapy. Gaston and Ring (1992) report no significant correlations between 
adherence and alliance.  
Gaston and Ring (1992) conducted further analysis that found a large 
correlation between adherence to exploratory strategies (those which address a 
patient’s reactions as problematic, and provoke anxiety) and alliance for the 
improved, but not for unimproved patients.  The authors suggest this indicates that 
with improved patients therapists employed more exploratory strategies when 
24 
 
alliance was better and that this was not the case with unimproved patients. It is 
equally possible that the use of exploratory strategies influenced alliance, or that a 
better alliance set the context for the use of more exploratory strategies, or that a 
third unmeasured variable influenced the relationship. That said, it seems that there is 
a different relationship between adherence and alliance in patients that demonstrate 
clinical improvement compared to those that do not.  
Gaston and Ring (1992) benefit from collecting a measure of adherence and 
alliance across therapy. However a mean of these measures is used and as such no 
inference can be made about how change in alliance and adherence scores across 
therapy may interact or influence outcome. Gaston and Ring (1992) use t tests and 
correlations which are less powerful than regression models in their ability to predict 
outcome and limit claims of causality. Gaston and Ring (1992) suffer from having a 
small sample size (n=10) and provide no information on how this sample was 
selected. The adherence measure used is not a measure of adherence to a particular 
therapy but to various different strategies. Any correlations between the adherence 
and alliance could reflect a relationship between a particular strategy and alliance as 
opposed to adherence to a therapeutic protocol. Given the context of a brief dynamic 
therapy, and the authors finding that dynamic therapists placed more emphasis on 
exploratory strategies than cognitive therapists, it seems fair to accept the ratings for 
exploratory strategies as adherence to an ingredient of brief dynamic therapy. 
Gaston, Thompson, Gallagher, Cournoyer, and Gagnon (1998) draw on the 
same data set and methods as Gaston and Ring (1992) and considered participants 
from all active treatment arms of therapy in the trial; cognitive therapy, behavioural 
therapy, and brief dynamic therapy.   Gaston et al. (1998) report that the patient’s 
ability to form a working alliance with the therapist, termed ‘Patient Working 
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Capacity’ was significantly related to exploratory strategies, and had an inverse 
relationship with supportive strategies (supportive interventions are those which 
attempt to support or structure a patient’s sense of self and reduce anxiety). 
Correlations between adherence and other aspects of alliance were not significant. 
The authors point out, that although not significant, more exploratory interventions in 
the context of good alliances predicted better outcome and less explorative 
interventions in the context of poor alliances predicted worse outcome. 
Gaston et al. (1998) also looked at data from an individual session in the 
middle of therapy. The authors report that in behaviour therapy and cognitive therapy 
exploratory interventions interacted with patient working capacity to predict 
outcome; less exploratory interventions in the context of a better alliance predicted 
better outcomes. This relationship was not observed for brief dynamic therapy. 
Interestingly alliance was predictive of a reduction in depressive symptoms whilst 
explorative interventions were not. This indicates that considering adherence in 
isolation does not give a full picture. Alliance may be independently associated with 
outcome but may also interact with adherence to effect outcome. 
Gaston et al. (1998) report the first negative correlation reported in this 
review. This finding indicates a negative correlation between therapists’ use of 
supportive strategies and Patient Working Capacity. Interestingly this study reports 
the first significant interaction between alliance and adherence in predicting 
outcome, finding that in cognitive therapy and behaviour therapy less frequent use of 
exploratory strategies in the context of better alliances is beneficial for outcome. 
Interpretations of these findings are problematic as the measure of adherence used is 
designed to be used across therapeutic modalities and includes a number of different 
strategies.  The authors note that as such further analysis is required of the types of 
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exploratory or supportive techniques that are being employed as to whether they 
represent cognitive, behavioural or dynamic techniques. These results do indicate 
that adherence to different strategies have a different relationship with alliance and 
outcome.  
A final study reports no significant correlation between adherence to Problem 
Solving Therapy and alliance. Bambling et al. (2006) benefits from using both 
therapist rated adherence and observer rated adherence. However there is no 
information as to when adherence was measured, which measure (therapist or 
observer) was used in analysis, or the expertise of the raters. This limits 
interpretations that can be made about the association (or lack of) between adherence 
and alliance as it could be due to processes occurring between measurements.  
Summary of studies focused on depression 
This summary should be considered in the context of the limitations 
identified above. In CBT, two studies (Strunk, et al., 2010;Webb et al., 2012b) report 
significant correlations between alliance and adherence when measured within a 
single session. This pattern was also observed when using mean alliance and 
adherence ratings collected over the course of therapy (Strunk et al., 2012). None of 
these three studies found a significant interaction between adherence and alliance in 
predicting outcome. These findings indicate that in CBT for depression, adherence 
and alliance can have a significant positive association, but their interaction is not 
associated with clinical improvement.   
Using mean levels of adherence from a single session or multiple sessions 
across the course of therapy cannot inform us of the relationship between the 
variables over time. One study (Minonne, 2008) indicates alliance early in therapy 
may be associated with adherence later in therapy. This could be interpreted as a 
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strong alliance setting the context for greater levels of adherence. That is, in 
conditions of a strong alliance, therapists are able to successfully implement and 
adhere to a therapeutic intervention. This relationship was statistically non-
significant and was not found across both types of therapy being investigated (CBT 
and IPT), so this interpretation is made tentatively. 
Another study highlights the importance of considering the relationship 
between adherence and alliance over time. Castonguay et al. (1996) claim that their 
descriptive analysis indicates that therapists increase adherence in an attempt to 
repair a disrupted alliance. This further weakens the alliance and has a detrimental 
effect on outcome. This association is not statistically significant making the 
assertion that adherence impacts negatively on alliance problematic. Although the 
results do indicate that alliance and adherence may be associated and interact in a 
way that will not be detected using analysis of means. Furthermore it indicates that 
flexibility in adhering to a model may be important.  
Results from another study by Gaston et al. (1998) support the idea that 
therapists are flexible to the aspects of a model they adhere to, dependent on the 
context of the alliance. Gaston et al. (1998) found a positive association between 
explorative interventions and alliance and a negative association between supportive 
strategies and the alliance. Although using correlations it is not possible to infer 
causality, these results could be interpreted as therapists using more supportive 
strategies in conditions of a weak alliance, in an attempt to repair it. In conditions of 
strong alliance therapists are able to focus on explorative strategies focused on the 
patient’s problematic reactions. Again it is of note that other correlations between 
adherence and alliance were not significant. 
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Results from these studies indicate that adherence and alliance often have an 
association with each other, and that the aspects of the model being adhered to may 
be affected by the quality of the therapeutic alliance. It appears that it is important to 
consider how adherence and alliance are associated and interact over time as opposed 
to using data from a single time point, or a mean from multiple time points. There 
does not seem to be significant evidence that adherence has a detrimental effect on 
alliance. As to the interaction between the variables impacting on outcome, the 
majority of studies found no interaction. This may be because no study assesses the 
impact on outcome of the interaction between adherence and alliance over time. One 
exception (Gaston et al.,1998) found that less use of exploratory interventions in 
CBT in the context of a better alliance predicted better outcomes. However, 
interpreting this finding is problematic as ‘explorative strategies’ may represent 
dynamically orientated interventions. It may be that when cognitive therapists 
employed less use of dynamically orientated interventions in the context of a good 
alliance patient outcome improved. This could reflect cognitive therapists using non- 
dynamic strategies not detected by the adherence measure. One other (Gaston & 
Ring, 1992) study indicates that adherence was associated with alliance, but only in 
patients that demonstrated clinical improvement.  Not all associations were found to 
be significant which could represent adherence to different strategies having different 
relationships with alliance and outcome. 
Studies focusing on substance disorders 
Five studies (Table 3) focused on adherence and alliance with participants 
with substance disorders. All studies appeared to use valid assessment with 
participants meeting Diagnostic and Statistical Manual of Mental Disorders (DSM) 
criteria for a substance use disorder.  Studies varied about when in therapy adherence 
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and alliance were assessed. Where presented, inter-rater reliability coefficients were 
adequate, ranging from moderate to perfect agreement (Appendix A). Interestingly, 
three of the studies consider the relationship between curvilinear adherence and 
alliance. 
Carroll, Nich, and Rounsaville (1997) assess adherence and alliance at an 
early session of CBT or Clinical Management for cocaine dependent patients and 
report a significant moderate correlation between adherence to CBT strategies and 
alliance. This study benefits from conducting analysis on CBT and a control 
condition therefore increasing the likelihood of variability in levels of adherence. 
Another strength is that raters were blind to the therapy condition. However, the 
study offers no information about the relationship between the variables over time or 
across therapy, and does not investigate how  adherence and alliance interact over 
time to affect outcome. 
Hogue, Dauber, Chinchilla, Fried, Henderson, Inclan, Reiner, & Liddle 
(2008b) used means from assessments of adherence across the course of therapy and 
alliance collected at two time points. A significant moderate correlation between 
adherence and alliance in Cognitive Behavioural Therapy (CBT) was found. In 
Multi-Dimensional-Family-Therapy (MDFT), adherence and alliance were not 
significantly correlated. This study benefits from using measures of adherence and 
alliance from multiple points in therapy. The sample used consisted of participants 
for whom there was available assessment data. No analysis was conducted to identify 
if this sub sample differed systematically from the larger sample. Furthermore, only 
80% of the sample met criteria for substance use disorder. Alliance measures were 
not assessed for all participants, which could affect the pattern of results observed. 
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Table 3 
 
Studies focusing on substance use disorders 
 
Study Title Sample Therapy Primary Focus Adherence Measure  Alliance measure  Outcome 
Carroll et al. 
(1997) 
N=103 adults with 
cocaine dependence 
from a randomised 
control trial 
comparing CBT  to a 
control condition 
 
Condition 1: 
CBT 
 
Condition 2: 
CM 
Relationship 
between alliance 
and outcome in 
active versus 
control conditions 
CSPRS (adapted for 
treatment involved 
in this study) 
VTAS-observer 
rated 
NA 
Hogue et al. 
(2008b) 
N=136 substance 
abusing adolescents 
(DSM from a larger 
RCT comparing 
CBT (n= 62) MDFT 
(n=74) 
 
CBT 
 
MDFT 
 
16-24 weeks 
Assessing the 
qualities of an 
adherence measure 
Therapist Behaviour 
Rating Scale 
VTAS observer 
rated 
 
Gibbons et al. 
(2010) 
N=450 Adults with 
Marijuana 
Dependence from 
The Marijuana  
Condition 1: 
MET 
2 sessions 
 
Relationship 
between alliance, 
adherence and 
outcome 
Yale Adherence and 
Competence Rating 
Scale: Treatment 
Specific MET, CBT  
Client and 
Therapist Self 
report WAI  
Diagnosis 
assessed using 
SCID. ASI. 
Interview  
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 Treatment Project 
randomised to two 
therapy conditions 
Condition 2: 
Integrated 
MET, CBT 
and CM 
9 sessions 
 and CM scales; 
General Structure 
and Facilitative 
Scales. 
 assessing pattern 
frequency and 
pattern of drug 
use. 
Barber et al. 
(2008) 
N= 108 adult with 
dependence from 
Supportive 
Expressive dynamic 
therapy condition of 
NIDA Collaborative 
Cocaine  Treatment 
Study 
 
SET 
 
24 weeks 
Relationship 
between alliance 
adherence and 
outcome 
Adherence/Compete
-nce Scale for SET 
for cocaine 
dependence 
 
Adherence/Compete
-nce Sale for 
Individual Drug 
Counselling 
 
CALPAS self-
report and HAQ 
self-report 
ASI administered 
at baseline and 
then monthly (1-6 
months) 
Barber et al. 
(2006) 
N=96 from IDC 
condition of NIDA 
Collaborative 
Cocaine Treatment 
Study 
IDC 
 
24 weeks 
Relationship 
between adherence, 
competence, 
alliance and 
outcome. 
Adherence/Compete
nce Scale for IDC 
for cocaine 
dependence 
CALPAS self-
report and HAQ 
self-report 
ASI and BDI 
administered at 
baseline and then 
monthly (1-6 
months) 
        
MET=  Motivational Enhancement Therapy, CBT=Cognitive Behavioural Therapy,  CM=Case Management, WAI=Working Alliance Inventory, SCID= Structured Clinical 
Interview for DSM, ASI= Addiction Severity Index, VTAS=Vanderbilt Therapeutic Alliance Scale,  CSPRS =Collaborative Study Psychotherapy Rating Scale, NIDA= 
National Institute on Drug Abuse, IDC=Individual Drug Counselling, HAQ=Helping Alliance Questionnaire, BDI=Becks Depression Inventory, SET= Supportive 
Expressive Dynamic Therapy, CALPAS= California Psychotherapy Alliance Scales, MDFT= Multi Dimensional Family Therapy5 
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Gibbons et al. (2010) use adherence ratings gathered from assessments at 
each session and alliance assessed at session two of a two session Motivational 
enhancement intervention and a nine session, integrated MET, CBT and Clinical 
Management intervention. Gibbons et al. (2010) report no significant interaction 
between alliance and adherence in predicting outcome in either therapy. However a 
significant interaction was reported between curvilinear adherence and alliance in 
predicting outcome in the nine session intervention. This indicates that in the context 
of high alliance, adherence had less impact on outcome, but when alliance was 
weaker adherence was more influential.  
Interestingly neither linear nor curvilinear adherence was significant in 
predicting outcome when considered individually. A significant relationship was 
reported between alliance and outcome. This indicates that whilst alliance may be 
associated with positive outcome when considered in isolation the same cannot be 
said of adherence. However, curvilinear adherence and alliance may interact to 
predict outcome.  
This study benefits from assessing adherence at every session and conducting 
analysis considering curvilinear adherence. The majority of analysis presented in 
Gibbons et al. (2010) focus on adherence to MET (the adherence measure used 
includes CBT, Clinical Management, and general scales), however it is not clear 
whether analysis of the interaction between adherence and alliance uses MET 
adherence or a mean of all scales in the measure. Raters were blind to outcome. 
However, half the study sample were not assessed for adherence, and alliance was 
only rated at one time point. It is not clear how many raters routinely rated each tape, 
although inter rater reliability for a sample of nine tapes was excellent and the 
authors conduct a power analysis indicating the sample size is sufficient. Although 
33 
 
Gibbons et al. (2010) reports that in context of weaker alliance adherence was 
influential, there is no analysis conducted to inform how the level of adherence (e.g. 
low, moderate, high) is associated with better outcomes. 
Two other studies provide information about the relationship between 
curvilinear adherence, alliance and outcome using data from a large randomized 
control trial investigating treatment for cocaine dependence. Barber et al. (2006) 
report a significant interaction between curvilinear adherence to Individual Drug 
Counselling (IDC) techniques and alliance in predicting outcome. This relationship 
was observed using alliance data collected at sessions two and five using two 
measures of alliance. These results indicated that a strong alliance negated the impact 
of adherence and a weaker alliance was associated with better outcomes when there 
were moderate levels of adherence. Interestingly in this study neither linear 
adherence nor alliance significantly predict outcome alone, however, curvilinear 
adherence did predict outcome. This indicates that only considering the contribution 
of linear adherence and alliance to outcome does not give a full picture. It is 
important to consider curvilinear adherence. Furthermore it is important to consider 
the interaction between curvilinear adherence and alliance in order to understand the 
role of these variables in predicting outcome. 
Barber et al. (2008) reports data from the Supportive Expressive Dynamic 
Therapy (SET) condition of the trial. Using the same methods as the previous study 
the authors found an interaction between curvilinear adherence to SET and one of the 
measures of alliance at session two in predicting outcome. These results indicated 
that in the context of a poor alliance, moderate adherence was slightly better for 
outcome than low or high levels of adherence. In the context of a strong alliance, low 
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adherence was associated with better outcomes than when adherence was moderate 
or high.  
Interestingly when considering the variables individually, greater adherence 
to SET predicted worse outcome whilst there was no significant relationship between 
curvilinear adherence and outcome. There was no significant relationship between 
alliance at session two and outcome, but one of the measures of alliance at session 
five was associated with better outcome. These findings indicate that considering the 
contributions of alliance and adherence in isolation do not give a full picture. It is 
important to consider their interaction, particularly using curvilinear adherence to 
understand their relationship with outcome. 
Further analysis considered the subscales of the SET adherence measure. 
Although neither of the subscales were independently associated with outcome, a 
significant interaction was found between curvilinear adherence to interpretive and 
clarifying techniques and both measures of alliance in predicting outcome. No 
interaction was observed between supportive techniques and alliance in predicting 
outcome. Barber et al. (2008) also investigated the impact of the incidental use of 
IDC techniques. The authors found no significant interaction between curvilinear 
adherence to IDC and alliance in predicting outcome. It is of note that IDC was 
measured for a subsample of participants. These findings indicate that adherence to 
different types of strategy have different relationships with alliance and outcome. 
These two studies benefit from using raters blind to outcome, using two 
measures of alliance collected at two time points and conducting analysis 
investigating curvilinear adherence. This study also controlled for a number of 
baseline characteristics as covariates.6  
                                                 
6 Site, (as it was a multi-site trial) baseline score of outcome variables, psychiatric severity and 
socialisation score of the California Personality were entered as covariates. 
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Summary of studies focussing on substance use disorders 
Two studies report significant correlations between adherence and alliance in 
CBT (Carroll et al., 1997;  Hogue et al., 2008b). One study fails to find a correlation 
between the variables in MDFT (Hogue et al., 2008b). Two other studies also 
indicate that adherence in different treatment conditions (Gibbons et al., 2010) or to 
different specific strategies (Barber et al., 2008) have different relationships with 
alliance and outcome. It is of note that none of these studies report a negative 
association between the variables, supporting the assertion that adherence does not 
have a negative effect on alliance. 
Three studies report on the interaction between adherence and alliance in 
predicting outcome (Barber et al., 2006; Barber et al, 2008; Gibbons et al., 2010). 
The results indicate that whilst adherence and alliance may not predict outcome 
when considered in isolation, a different pattern of results emerges when considering 
the relationship between curvilinear adherence, alliance and outcome. Two of the 
studies found that in the context of high alliance, adherence had no impact on 
outcome (Barber et al., 2006; Gibbons et al., 2010). Whilst one study found that low 
adherence was more beneficial to outcome in conditions of high alliance (Barber et 
al., 2008). All three studies report a relationship between curvilinear adherence and 
outcome in the context of a low alliance. Two of the studies agree that in such 
conditions moderate adherence is associated with best outcome. It appears that there 
is a curvilinear relationship between adherence and alliance in predicting outcome 
which has clinical implications. It may be that in the context of a high alliance, 
adherence does not matter much, or possibly that low adherence is best. However in 
conditions of a low alliance it seems that moderate adherence is best. This may 
reflect therapists using a therapeutic model flexibly, using strategies to build the 
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alliance whilst remaining largely on model and adherent to theory specific 
interventions.  
Studies focusing on other clinical presentations 
Seven studies focused on other clinical presentations (Table 4). All included 
participants meeting criteria for a psychiatric diagnosis with the exception of Pavio, 
Holowaty, & Hall (2004) which included adult survivors of childhood abuse, 
although the authors note that 54% of the sample met criteria for post-traumatic 
stress disorder (PTSD) on the PTSD Symptom Severity Interview.  Where presented 
inter-rater reliability coefficients for adherence and alliance were adequate, ranging  
from moderate to perfect agreement (Appendix A) 
Evans-Jones, Peters and Barker (2009) used adherence and alliance data 
collected from a single session of CBT for psychosis. Due to the authors conducting 
multiple comparisons a value of  p < .01 was used. The following correlations are 
considered trends. The authors report a moderate correlation between patient rated 
alliance and adherence. Alliance ratings were found to be higher when a CBT 
formulation had been presented than when it had not. There were no differences 
between therapist rated alliance when a formulation had been presented and when it 
had not. This study benefits from using a theory specific adherence measure and 
presents analysis that indicates that the alliance measure was measuring a construct 
that was independent of therapist and client characteristics. It is limited by its 
relatively small sample size (n=24). 
Goldman and Gregory (2009) found no significant correlation between mean 
adherence and alliance in long term dynamic deconstructive psychotherapy for adults 
with a diagnosis of borderline personality disorder and alcohol use disorders. This 
study benefits from using a therapy specific measure of adherence and collecting 
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Table 4 
 
Studies focusing on other clinical presentations 
 
Study Title Sample Therapy Primary Focus Adherence Measure  Alliance measure  Outcome 
Evans-Jones et al. 
(2009) 
N=24 adults with 
schizophrenia 
spectrum diagnosis. 
CBT for psychosis. 
Patients between 
session 2-9 
Relationship between 
client and therapist 
factors and alliance. 
Presentation of a Case 
Formulation Checklist  
 
Cognitive behaviour 
therapy for psychosis 
checklist  
 
WAI client and 
therapist self report 
NA 
Goldman & Gregory 
(2009) 
N=10 adults with 
BPD and Alcohol 
Misuse from DDP 
condition of RCT 
 
DDP 
 
12 months 
Relationship between 
adherence and 
outcome 
DDP adherence measure 
 
 
Observer rated WAI NA 
Ogrodniczuk, & 
Piper (1999) 
N=144 adults with 
Axis 1 (73%) and 
Axis 2 (60%) 
diagnoses from 
randomised 
Comparative  trial 
Condition1- Short 
term interpretive 
Therapy 
 
Condition 2: short 
term supportive 
therapy 
 
20 sessions 
 
 
The development of  
adherence measures 
Interpretive and 
Supportive Techniques 
Scale: Interpretive and 
Supportive subscales. 
Measure of ‘working 
relationship’. Therapist 
self report 
NA 
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Gaston,  et al. (1994) N=32 adults 
diagnosed with 
neurosis (66%) or 
personality disorder 
(33%) from short 
term (n=17) and 
long term (n=15) 
conditions of RCT 
Short term analytic 
psychotherapy 
Average 22 weeks 
 
Long term analytic 
psychotherapy 
Average 76 weeks 
Relationship between 
adherence, alliance 
and outcome 
ITS: Explorative and 
Supportive subscales 
Observer rated 
CALPAS: Patient 
Working Patient 
Commitment Subscales 
Depression Anxiety 
Scale of the Psychiatric 
Status Schedule and the 
IBS 
Pavio et al. (2004) N= 37 adults 
recruited through 
newspaper 
advertisement. 
Adults who 
experienced 
childhood abuse 
suitable for short 
term insight 
orientated therapy 
EFT 
 
Average 19 
sessions 
Evaluating the 
relationship between 
adherence, 
competence and 
outcome. 
 
 
 
 
 
 
The EFT adherence 
checklist 
WAI- client self report NA 
Liber, et al. (2010) Data from children 
with diagnoses of 
various anxiety 
disorders taken 
from a larger 
Randomised trial 
comparing CBT 
with Group CBT. 
N=52, but analysis 
presented based 
only on children in 
CBT condition n=? 
 
Individual CBT 
based on Australian 
FRIENDS manual 
 
14 sessions 
Relationship between 
alliance, adherence 
and outcome 
Australian adherence 
protocol for Friends 
Treatment 
Therapist  Process 
Observational Coding 
System for Child 
Psychotherapy- 
alliance scale (TPOCS-
A) 
NA 
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7 Full references for adherence, alliance and outcome measures can be found in appendix B 
 
Loeb et al. (2005) N=81 women with 
diagnosis of 
Bulimia Nervosa 
from a larger RCT 
CBT and IPT 
 
19 sessions 
Relationship between 
alliance, adherence 
and outcome 
Measure derived from 
items from Minnesota 
Therapy Rating Scale and 
the Therapy Rating Scale 
producing individual 
measures for IPT and 
CBT. 
VTAS- observer rated NA 
BPD=Borderline Personality Disorder,  DDP=Dynamic Deconstructive Psychotherapy, RCT=Randomised Control Trial, WAI-Working Alliance Inventory, ITS=Inventory of 
Therapeutic Strategies,  CALPAS= California Psychotherapy Alliance Scales, IBS= Interpersonal Behaviour Scale, CBT=Cognitive Behaviour Therapy, IPT=Interpersonal 
Therapy, EFT=Emotion Focused Therapy7 
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adherence and alliance data from multiple time points, although using a mean score 
cannot inform us to the relationship between the variables over time. Raters were 
blind to study outcome. However it appears the same raters rated both alliance and 
adherence. Furthermore one of the raters was the second author of the paper. It is 
possible that raters hypothesis about the relationship between adherence, alliance and 
outcome may have biased ratings. This study is limited by a particularly small 
sample size (n=10).  
Ogrodniczuk and Piper (1999) used average ratings of adherence and alliance 
taken from nine sessions across the course of 20 session interpretive therapy and 
supportive therapy treatment conditions for patients with axis I and axis II diagnosis. 
Small significant correlations between adherence and alliance across both conditions 
were found. A significant moderate correlation was found between adherence to 
interpretive techniques and alliance in interpretive therapy. A small significant 
correlation was found between adherence to supportive techniques and alliance 
across both conditions. This study benefits from using a large sample, multiple raters, 
and adherence and alliance data collected at multiple points across the course of 
therapy. Unfortunately, there is no information about the relationship between 
adherence and alliance in the supportive therapy condition as no correlations are 
presented. Finally a measure of ‘working relationship’ was for alliance which may 
not be comparable to other measures of alliance used in process-outcome research. 
Gaston, Debbane, Bienvenu, and Grant (1994) also use alliance and 
adherence ratings taken from sessions across the course of short term and long term 
analytic therapy for patients with diagnoses of neurosis and personality disorder. 
Small and moderate correlations between exploratory strategies and alliance were 
found. The patient’s ability to form a working alliance, and the patient’s commitment 
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to treatment had negative correlations with adherence to supportive strategies. This 
indicated that when alliance is higher, adherence to supportive strategies was lower.  
In short term analytic therapy the interaction between adherence and alliance 
was not significant in predicting outcome. In long term analytic therapy the authors 
report several significant interactions between aspects of adherence and alliance in 
predicting outcome. The authors report that the results indicate that when alliance 
was stronger there were better outcomes when there was more use of explorative 
strategies and less use of supportive strategies. For weaker alliances there were better 
outcomes when there was less use of explorative strategies and more use of 
supportive strategies. Interestingly when considered individually neither supportive 
strategies, explorative strategies, nor alliance were significantly associated with 
outcome. This is with the exception of the patient’s ability to form a working alliance 
which significantly predicted interpersonal behaviour at outcome. This indicates that 
considering the contributions of these variables to outcome in isolation does not give 
a full picture and it is necessary to consider their interaction. These results also 
support the argument that adherence to different strategies have different 
relationships with alliance and outcome. 
This study benefits from collecting data from time points across therapy but 
again uses a mean score, so no inference can be made about temporal relationships. 
The multiple regression analysis benefits from controlling for initial levels on 
outcome variables. The authors note the analysis is based on only five observations 
per predictor so results should be considered preliminary. Furthermore this study is 
limited by a small sample size (n=10).  
Pavio et al. (2004)  report a significant moderate correlation between alliance 
and adherence across the course of emotion focused therapy for adult survivors of 
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childhood abuse. This study benefits from collecting alliance data at each session and 
adherence data across the course of therapy. However, there is limited information 
on the rating of adherence with regard to the number of sessions rated or how many 
raters were used. Participants were recruited from newspaper advertisements offering 
free therapy. Those who met criteria for suitability for therapy based on motivation 
and capacity to form a therapeutic relationship were included. It is possible that 
individuals that seeks therapy via a newspaper advertisement with high levels of 
motivation and ability to form an alliance may have higher alliances and differ 
systematically from other groups of patients. This could limit the generalisability of 
these findings. This study uses a relatively small sample size (n=32) and presents 
multiple comparisons. The authors note that the study is exploratory so no 
Bonferonni corrections were made. The results should therefore be interpreted with 
caution.  
Liber et al. (2010) assessed adherence to CBT and alliance at early and late 
sessions of treatment of childhood anxiety disorders. The authors report a significant 
moderate correlation between early adherence and early alliance, and between late 
adherence and late alliance. This study suffers a number of limitations. Children in 
the study are diagnosed with a variety of diagnoses. It is possible that children with 
different diagnoses differ systematically in ability to form working alliances or 
impact differently on a therapist’s ability to adhere to treatment. The study considers 
children in group and individual CBT. It does not provide information as to how 
many are in each condition but it is likely to be a relatively small sample given the 
size of the entire sample (n=52). Whilst ratings of adherence and alliance were 
collected at the same session, only a sample of sessions were coded. Finally although 
authors describe a measure of adherence, the description states that raters judge 
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therapists on how well they meet the aims of the therapeutic activity which could be 
considered a measure of competence. 
Using a sample of patients with a diagnosis of Bulimia Nervosa treated with 
CBT or IPT, Loeb et al. (2005) collected alliance and adherence data from an early, 
middle and late session of 19 session CBT and IPT interventions. Loeb et al. (2005) 
considers the relationship between adherence and the therapist factor (contribution 
the therapist makes to the alliance) and the patient factor (patients contribution to the 
alliance and mutual engagement of therapist and patient) of the alliance individually. 
The authors report many significant correlations between adherence and alliance 
across the course of therapy in both CBT and IPT. This study benefits from using 
random number tables to identify the sample used from the larger sample in the trial. 
The authors also report that the sample differed significantly from the larger sample 
on a number of baseline variables8. It is possible that these patient characteristics 
influence the therapeutic alliance, therapist adherence and the relationship between 
the variables. 
This study collects adherence and alliance data at the same session therefore 
any relationship between the variables is unlikely to be due to processes that occur 
between their measurements. Only one judge rated each session although reported 
interclass coefficients based on a sample of tapes are adequate. Unfortunately none 
of the multiple regression analyses reported include an alliance and adherence 
interaction term.  
Summary of studies focussing on other clinical presentations 
All the studies focused on other clinical presentations report significant 
correlations between adherence and alliance with the exception of one study which 
                                                 
8 The current sample had lower scores on measures of shape concern, weight concern and eating 
concern and a longer history of purging. 
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had a particularly small sample size (Goldman & Gregory, 2009). Again measures of 
adherence were often to particular strategies indicating that adherence to different 
strategies have different relationships between alliance and outcome. Results from 
one study indicate that the positive relationship between alliance and adherence is 
stable over time, finding significant correlations at three sessions spread over the 
course of therapy (Loeb et al., 2005). The only negative correlation reported (Gaston 
et al., 1998) indicates that therapists employ more supportive strategies when the 
alliance is weak, in an attempt to strengthen it. The results from this study also 
indicate that in the context of a strong alliance greater use of strategies that address 
patients’ problematic reactions and less use of supportive strategies is beneficial for 
outcome. Conversely in conditions of weak alliance, less use of strategies addressing 
problematic reactions and more supportive strategies are beneficial. These findings 
could be interpreted as therapists using strategies flexibly, to address alliance to 
produce the best outcome. When necessary therapists adhere to strategies within the 
model that address the therapeutic alliance. When alliance is strong therapists are 
able to focus on strategies that address problematic functioning directly. 
These results indicate there is often an association between aspects of 
adherence and alliance. Importantly there is no significant evidence that adherence 
has a detrimental effect on alliance. With regard to predicting outcome the results 
indicate that flexible adherence is associated with best outcome.   
Discussion 
This review captures the developing understanding about the relationship 
between adherence, alliance and outcome in individual psychotherapy. The review 
includes studies focusing on a range of therapies, using a number of measures of 
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adherence and alliance with patients presenting with depression, substance use 
disorders, and a range of other clinical presentations. The findings from this review 
are summarised and synthesised below, followed by discussions of key 
considerations with regard to measurement of variables and limitations of this 
review.  
The results indicate that adherence and alliance are often associated. Not all 
analysis report significant correlations. Whilst this may be due to methodological 
limitations it is likely that adherence to different strategies have different 
relationships with alliance and outcome. Importantly, this review suggests that 
adherence does not have a detrimental effect on alliance. The literature also indicates 
that it is important to consider the relationship between the variables over time and 
whether a good alliance sets the context for therapists to adhere to the therapeutic 
model. Most studies do not report an interaction between adherence and alliance in 
predicting outcome when using mean measurements. This review suggests that 
research should consider of curvilinear adherence. Results indicate that in conditions 
of low alliance, moderate adherence is best for outcome. Considering this finding 
alongside results indicating that therapists use a greater frequency of supportive 
strategies when alliance is strained (which is associated with better outcome) 
indicates that a flexible approach is best. When there is a strain on the alliance, 
patients benefit most when therapists engage in interventions to support the alliance 
but remain largely consistent with their model (i.e. moderate adherence). It is of 
course easier to remain adherent to an approach and support alliance if the 
therapeutic approach includes interventions to help to build the therapeutic alliance 
(i.e. supportive strategies). This has obvious clinical implications. Therapy models 
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should include strategies to help foster therapeutic alliance, and therapists should 
employ models flexibly addressing ruptures in the therapeutic alliance appropriately. 
Issues of Measurement 
Articles considering depressed patients include cognitive, behavioural, 
dynamic, problem solving, and psycho-education treatment. Therefore, although 
adherence can be considered a common factor, the measures of adherence will 
invariably be measuring different techniques across therapies. This makes 
generalisations about the relationship between adherence and alliance problematic. 
Secondly, often studies use a mean score for a particular part or scale of an 
adherence measure, or assess adherence to one particular technique. Therefore any 
reported relationships between adherence and alliance could be specific to the 
intervention measured and relationships between adherence to other aspects of a 
treatment and alliance will not be detected. It is unclear what exactly some measures 
of adherence are measuring. For example the Inventory of Therapeutic Strategies is 
described as a tool to measure specific ingredients across psychotherapies. Although 
the authors state that it is informed predominantly from a dynamic perspective, it is 
also informed by cognitive and behavioural perspectives. It is therefore not possible 
to know whether the adherence-alliance relationships observed reflect adherence to 
dynamic, cognitive or behavioural techniques.  
With regard to alliance, four measures are used across the studies focusing on 
depression. Some studies employ the full measures, some studies use subscales from 
the measures. It has been shown that these measures’ shared variance is less than 
50% (Horvath et al, 2011). It is possible that studies could have produced different 
patterns of results had they used a different measure of alliance. This is highlighted 
in the Barber et al. (2006) study that reports different results using two different 
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measures of alliance in the same analysis. There also may be differing relationships 
with adherence when considering self report, patient rated, and therapist rated 
alliance. This is highlighted by Evans-Jones et al.  (2009) who reported different 
relationships with adherence for therapist rated and patient rated alliance. Due to the 
diversity of the measures it is difficult to make generalisations about adherence-
alliance relationships.  
Limitations 
In addition to individual study limitations a number of more general 
limitations should be noted. With regard to statistical analysis, no inference can be 
made about direction of causality and whether there is a third unmeasured variable 
that is affecting results when using correlational analysis. Studies that present 
regression analysis typically do not account for any variables other than alliance and 
adherence with the exception of one study controlling for site in a multi-site trial 
(Strunk et al., 2010), and two studies controlling for prior symptom change (Strunk 
et al., 2012; Webb et al., 2012b). Finally this review indicates that it is important to 
consider curvilinear adherence relationships, only three of the studies do this. 
Another limitation is with regard to when measures of alliance and adherence 
are taken. Using adherence and alliance measures from a single session restricts the 
possibility of any observed relationship being due to processes occurring between 
their measurement but cannot inform us about the relationship between adherence 
and alliance during other sessions of therapy. Studies using mean measures of 
adherence and alliance taken from across the course of therapy are limited as they 
cannot inform us to the changing relationship or interaction between the variables 
across the course of therapy. This is highlighted by Gaston et al. (1998) which 
reports a different pattern of results when using a mean measure of alliance 
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compared to a measure of alliance from a single session. With regard to predicting 
outcome, many studies predict outcome post treatment using measures of adherence 
and alliance taken earlier in therapy. Therefore, any relationship between predictor 
variables could be due to processes occurring between the adherence/alliance 
measurement and the measurement of outcome.   
Although many studies use similar measures and some studies draw on the 
same data set, there remains significant variability in the measures used. Studies also 
vary on the clinical presentation that is focused on and the type of therapy used. 
Beutler (1979) questioned the legitimacy of collapsing groups of patients and 
therapies when conducting a meta-analysis and the same concern is relevant here 
when considering these results together. Studies also vary on the sample size used, 
some of which are particularly small. As mentioned above studies also vary on the 
timing of measurement of the variables and on statistical analysis conducted. The 
heterogeneity of the literature limits generalisations that can be made about the 
patterns of relationships observed. 
Future Research 
The findings of this review indicate that the relationship between adherence 
and alliance, and their interaction in predicting outcome are worthy of further 
investigation. There is a relatively small amount of literature considering the 
interaction of these variables. More research involving different therapies and 
clinical presentations is required for replication and further investigation. 
Future research should employ measures of adherence and alliance at 
multiple time points across the course of therapy. This will allow for the 
investigation of the relationship between these variables over time, without relying 
on means which has limitations identified above. Similarly outcome should be 
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collected at multiple time points across the course of therapy to limit the possibility 
of any observed relationship being due to undetected processes occurring in between 
measurements, and develop the understanding of the relationship between adherence 
and alliance in predicting outcome across the course of therapy. Collecting data at 
multiple time points in this way will also make it possible to assess if therapists are 
using flexible adherence. This review also indicates that future research should 
consider the interaction between curvilinear adherence and alliance in predicting 
outcome. 
When considering measures of adherence it is important that adherence to 
specific interventions as well as a more general theoretical approach is assessed. This 
will allow for the identification of ‘active ingredients’ in therapy but also the 
consideration of adherence as a common factor. This will also reduce the possibility 
of adherence to theory specific interventions that may be related to alliance going 
undetected. With regard to measures of alliance, research should be mindful of the 
variation in the definition and diversity of measures and also consider any overlap 
between the measure of adherence and alliance in terms of what phenomena they are 
measuring. 
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The relationship between alliance, adherence, and attendance when 
using a contingency management intervention in opiate substitution 
therapy 
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Abstract 
Aims  This study investigates whether the use of a contingency management 
(CM) intervention improves attendance to Opiate Substitution Therapy (OST) 
compared to treatment as usual (TAU). The relationship between client factors, 
therapeutic alliance, therapist adherence and attendance is considered. 
Methods: Data from 47 participants receiving a CM intervention and OST, and 30 
participants receiving OST alone (TAU) who had reached session four in the 
PRAISe trial were used. The CM group and TAU group were compared on levels of 
attendance. The relationship between client variables (demographic information, 
social functioning, previous treatment experience, and motivation), therapeutic 
alliance, therapist adherence, and attendance was investigated. The effect of the 
interaction between therapeutic alliance and curvilinear adherence on levels of 
attendance was focused on. 
Results  Participants receiving the CM interventions had higher levels of 
attendance (77%) than the TAU (41%) group. High levels of alliance were observed 
in the CM group. Within the CM group higher levels of alliance were associated 
with higher levels of attendance. No relationship between client factors and 
therapeutic alliance, adherence or attendance was found. Alliance did not interact 
with adherence to impact on levels of attendance. 
Conclusions CM interventions are effective in increasing attendance in OST. It is 
hypothesised that the provision of an incentive promotes the therapeutic alliance and 
is sufficiently rewarding to increase attendance. Failure to replicate previous findings 
of an association between client factors and attendance, and of an interaction 
between curvilinear adherence and alliance effecting outcome are thought to be a 
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result of the short period of therapy considered, a ceiling effect in alliance, and a 
small sample size. 
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Introduction 
Drug misuse is a persistent problem for society. Of an estimated 330,000 
problem drug users in the England, 280,000 are believed to be opiate users (Hay, 
Gannon, MacDougall, Millar, Eastwood & McKeganey, 2007). Amato, Davoli, 
Perucci, Ferri, Faggiano and Mattick (2005) describe how opiate dependence has 
huge economic and social costs due to crime, unemployment, relationship 
breakdown and cost of law enforcement. Class A drug use, the highest classification 
of controlled drugs considered to be the most harmful to the individual and society, 
was estimated to cost society £15.4 billion in 2003/2004 (Home Office, 2008). 
Furthermore opiate user’s mortality rate is more than 10 times that of the general 
population (Cornish, MacLeod, Strang, Vickerman, Hickman , 2010)  with mortality 
rates of untreated heroin dependence estimated at 1-3% a year, half of which is 
attributed to overdose (Darke & Hall, 2003; Sporer, 1999). 
Opiate Substitution Therapy 
Although abstinence is the long term goal of treatment for opiate addiction, 
detoxification is recognised as a key stage to reach this goal (NICE, 2007). Opiate 
Substitution Therapy (OST) is recommended as the first line treatment in opioid 
detoxification (NICE, 2007). OST has been shown to be effective in suppressing 
heroin use (Amato et al., 2005), has an extensive evidence base (NICE, 2006) and is 
shown to be cost effective (Godfrey, Stewart, & Gossop, 2004). OST is a 
maintenance approach that aims to provide stability by reducing craving, preventing 
withdrawal, eliminating the hazards of injecting, freeing the person from 
preoccupation with obtaining illicit opioids, and to enhance overall function. A 
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substitution opioid is prescribed (typically methadone or buprenorphine) to reduce 
and stop illicit use.  
Retention and treatment duration have been repeatedly found to be associated 
with drug treatment outcomes (Zhang, Friedmann, & Gerstein, 2003). OST has high 
attrition, with reported drop-out rates of 40% within less than 3 months (Mattick, 
Breen, Kimber & Davoili, 2007; Gossop, Marsden, Steward & Treacy, 2001), rising 
to over 50% within 6 months (Mattick, et al., 2007) and over 60% at a year (Ball & 
Ross, 1991).  
Contingency Management 
Contingency Management (CM) interventions are based on operant 
conditioning and involve the systematic application of behavioural consequences to 
promote change in behaviour (Higgins, Silverman & Heil, 2008). CM interventions 
have been developed to provide positive reinforcement for attendance, medication 
compliance and abstinence of street drugs. Petry (2006) states that CM programs 
typically include 3 basic components. First is the identification of a target behaviour 
such as attendance at a drug program or abstinence from illicit drug use . Second is 
the provision of an incentive when the target behaviour is achieved. Finally the 
incentive is withheld when the target behaviour is not achieved. Evidence from 
randomised control trials suggests that CM reduces attrition and illicit drug use, and 
increases attainment and retention of abstinence (NICE 2007).  
CM is identified as having the potential to increase and extend the benefit of 
OST and is recommended for UK implementation (NICE, 2007). However, there is a 
need to generate evidence about the feasibility, acceptability and clinical and cost 
effectiveness of CM interventions in the UK NHS drug treatment setting (NIHR, 
2012). Furthermore NICE (2007) recommends that research should focus on specific 
   62 
 
components of the program. This will develop the understanding of the process of 
change and ‘active ingredients’ of contingency management. The current study aims 
to address this question by considering the relationship between contingency 
management, attendance for treatment, client factors and therapy process variables. 
Specifically, therapeutic alliance and therapist adherence will be considered.  
Therapeutic Alliance 
Although various definitions exist, the term therapeutic alliance refers to the 
strength and quality of the relationship between the client and therapist (Horvath, 
2001).   Cahill et al, (2005) identify five dimensions; bond, partnership (agreement 
on tasks of therapy and shared goals), confident collaboration, openness to disclose 
and reveal personal material, and client initiative (the client taking responsibility for 
the direction of therapy). 
Alliance has been found to be consistently associated with outcome in 
various types of psychotherapy (Loeb et al., 2005) and a number of meta-analyses 
report a significant association between alliance and outcome in individual 
psychotherapy (Horvath & Symonds, 1991; Horvath, Del Re, Fluckiger & Symonds. 
2011;Martin. Garske, & Davis, 2000; Horvath & Bedi, 2002). Reviewing the 
substance misuse literature Meier, Barrowclough, and Donmall, (2005) report that 
alliance is a consistent predictor of engagement and retention. Meier et al. (2005) 
identify a number of client factors that predict a better therapeutic alliance in 
substance misuse treatment including; motivation, coping strategies for cravings, 
social support and a secure attachment style.  
There is a lack of empirical data regarding the therapeutic alliance in 
contingency management interventions but Petry (2006) suggests that providing 
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reinforcement may help to strengthen the therapeutic alliance. However, McQuaid, 
Bowden-Jones and Weaver (2007) highlights concerns that the use of incentives has 
the potential to damage the relationship between staff and clients. 
These findings indicate that it is important to consider the role of the 
therapeutic alliance when considering the efficacy of contingency management 
interventions reinforcing attendance. 
Adherence 
Adherence measures are used to assess the degree to which therapists are 
delivering the specified techniques of an intervention (Webb, DeRubeis & 
Barber,2010). They are used to ensure that treatment is delivered as intended and to 
provide information on which aspects, or ‘active ingredients’ of a treatment 
contribute to outcome. Despite the increasing importance attributed to adherence in 
the therapeutic outcome literature, a recent meta-analysis reports no significant 
relationship between adherence and outcome (Webb et al., 2010) in individual 
psychological therapy. In the substance misuse field findings are also unclear , one 
study report a positive relationship between adherence and outcome (Hogue et al 
.2008), another reports a negative relationship (Barber et al., 2006) and some studies 
report no relationship (Barber et al.m 2008; Gibbons et al., 2010).  
Adherence, alliance and outcome 
While some studies have investigated the effects of adherence and alliance on 
outcome independently, there are few studies investigating the interaction between 
adherence and alliance and their relationship to  outcome. Those that do indicate that 
it is important to consider curvilinear adherence (Kember, 2013). Investigating the 
interaction between curvilinear adherence and alliance allows for the consideration 
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of a non-linear relationship and how varying levels of adherence may interact with 
different levels of alliance.  
Results from three studies in the substance misuse field suggest a relationship 
between curvilinear adherence and alliance, and outcome. These studies indicate that 
in the context of a high alliance, adherence had no impact on outcome (Barber et al., 
2006; Gibbons et al., 2010), or that low adherence was most effective (Barber et al., 
2008). Whilst in the context of low alliance, moderate adherence was best (Barber et 
al., 2008; Barber et al., 2006).  This may reflect therapists using a therapeutic model 
flexibly, using strategies to build the alliance whilst remaining largely adherent to 
the  theory specific interventions. These findings indicate that it is important to 
consider the interaction between adherence and alliance and their relationship with 
attendance in contingency management interventions.  
Client factors 
A number of client factors have been identified as predictors of retention in 
OST including social stability (being married, employed and having fewer prior 
arrests), previous treatment experience, and motivation for treatment (Simpson & 
Joe, 1993; Joe, Simpson, & Broome, 1998;).  Frequency of drug use and age has also 
been found to be associated with outcome in OST.  Simpson, Joe, and Rowan-Szal 
(1997) found that older patients had better outcomes with regard to drug use, alcohol 
use and criminal behaviour.  The authors also reported that lower frequency of opiate 
use was associated with better outcomes. Similarly McLellan et al. (1994) report that 
severity of opiate use prior to treatment predicted substance use at follow up. 
Simpson et al. (1997) also suggest it is important to consider several other client 
factors including ethnicity and gender. 
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Aims of the current study 
In order to enhance treatment outcomes in substance misuse, further research 
focusing on patient attributes and therapeutic process is needed (Simpson et al., 
1997). This study aims to investigate the relationship between adherence and 
alliance, client factors and attendance in contingency management interventions in 
OST. This will begin to develop an understanding of the therapeutic processes in 
contingency management interventions in OST. It will also begin to address a more 
general gap in the literature as to how the interaction between adherence and alliance 
may be associated with outcome. 
The current study uses data from the on-going Positive Reinforcement 
targeting Abstinence In Substance misusE (PRAISe) trial; a National Institute of 
Health Research (NIHR) funded trial which aims to develop the UK evidence base 
of Contingency Management (CM) in Opiate Substitution Therapy (OST). It aims to 
assess the acceptability, feasibility, clinical and cost effectiveness of CM to improve 
treatment attendance and abstinence from street heroin. It uses a cluster randomised 
design to compare 3 arms; Treatment As Usual (TAU) and two 12 week contingency 
management programmes targeting treatment attendance and abstinence of opiates 
respectively. Recruitment into the trial is on-going. The current study uses data from 
the first four treatment sessions to investigate the effect of CM interventions on 
attendance and explore the relationship between client factors and therapeutic 
process variables. During the first four sessions reinforcement is given for attendance 
in both treatment arms. Clients are not reinforced for abstinence until the fifth 
session (for further details of the interventions see NIHR, 2012).  
The current study will investigate whether the use of contingency 
management interventions in the PRAISe trial is associated with increased 
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attendance. Client factors previously found to be associated with retention in OST 
including social functioning, previous treatment experiences and motivation for 
treatment will be investigated for an association with attendance. The current study 
will also: a) investigate whether the level of alliance is associated with increased 
attendance in contingency management interventions, and; b) will build on previous 
research cited above to investigate the relationship between adherence and alliance 
in predicting attendance in contingency management interventions. 
Hypotheses 
1. Attendance will be higher in contingency management arms than the TAU 
arms 
2. Client factors including social functioning, number of previous OST 
treatments and motivation for treatment will be associated with level of 
attendance 
3. Higher levels of alliance will be associated with higher levels of attendance. 
4. In contingency management treatment the interaction between adherence and 
alliance will be associated with level of attendance. When alliance is high, 
the level of adherence will not have an effect, or low levels of adherence will 
be associated with increased attendance. When alliance is low moderate 
levels of adherence will be associated with increased attendance. 
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Method 
Participants 
Participants in PRAISe trial 
All clients starting a new OST program at all sites are being screened for 
eligibility for the PRAISe trial. Inclusion criteria are: 
 aged >18 seeking new episode of OST treatment (not transferring from 
prison or another drug service) 
 regular user of street heroin in preceding one month (as evidenced by self 
report >15/30 days in preceding month (at least 3 days a week), and all urine 
drug screen (UDS) in previous month positive for opiates (must have at least 
1 UDS result in last month), opiate dependent (meeting ICD-10 criteria), and 
 at liberty to participate in the study for 24 weeks. 
 willing and able to provide informed consent. This will exclude those patients 
who cannot read English AND require the service of an interpreter to 
understand a brief oral description of the study – these patients cannot be 
considered to have given informed consent and will NOT be entered in to the 
trial. 
• Willing to receive 12 week CM intervention reinforcing abstinence 
Exclusion criteria include: 
 pregnant or breastfeeding 
 active severe mental health illness or significant cognitive impairment 
 A client who has entered the trial may not re-enter. 
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Participants in the current study 
The current study draws on a sample of 76 participants who have reached 
week four of the study from six sites. 47 participants were identified from four 
contingency management sites and 30 from two treatment as usual sites. Participants 
who had been discharged (n=3) or transferred (n=1) before session four and those 
whose research file was missing (n=2) were not included in this sample. The 
majority of the sample were male (79%), White British (63%), with an average age 
of 38 (S.D =8.94). 
Power Analysis 
Power analysis was informed by the work of Barber et al. (2008). The authors 
investigated the interaction between curvilinear adherence to Supportive Expressive 
Therapy and alliance in predicting change in drug use. Barber et al. (2008) found a 
small effect size (r= 0.24). Power calculation was carried out using G*Power  3 
computer program (Faul, Erdfelder, Lang and Buchner, 2007), specifying alpha = 
5% and desired power = 80%. The required sample size is estimated at 143. This 
indicates that unless effect size in the current study is considerably larger then it is 
unlikely to be detected in the current sample. 
Ethics 
Ethical approval for the PRAISe trial was granted by the National Research 
Ethics Service South East Coast- Surrey (Appendix C).  
Interventions 
Treatment as usual 
Treatment as usual consists of Opiate Substitution Therapy involving the 
prescription of either methadone or buprenorphine and 12 weekly key work sessions.  
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Key work sessions include harm reduction, care planning, reviewing progress, risk 
assessment, brief psycho-social interventions and help addressing social problems 
(NIHR, 2012). 
Contingency management   
CM interventions consist of TAU and a contingency management 
intervention. Timely attendance is the target behaviour which is reinforced using a 
£10 supermarket voucher as an incentive. The PRAISe protocol states that CM 
interventions should be delivered using an empathic and positive approach which 
rewards desired behaviours and is neutral to undesired behaviours (NIHR, 2012).  
During the intervention target behaviour and incentives should be clearly identified, 
and an explicit link made between the receiving the incentive and achieving the 
target behaviour. When a target behaviour is not achieved this should be explicitly 
linked to the absence of giving the incentive.  
Process measures 
Therapeutic alliance 
Clients receiving the CM intervention are asked to rate the level of 
therapeutic alliance using the Agnew Relationship Measure-5 (Cahill et al, 2011). 
Participants are asked to indicate their level of agreement on 5 items pertaining to the 
therapeutic alliance on a Likert scale ranging from 1-7 yielding a total score out of 
35.  
Adherence to CM model 
The Adherence Measure for PRAISe Contingency Management Program 
Attendance and Abstinence versions were used to assess therapist adherence 
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(Appendix D).  These measures were developed by myself and Professor Steve 
Pilling, a principal investigator on the PRAISe trial.  
The measure maps onto the PRAISe protocol which outlines a sequenced 
approach for the delivery of CM. This involves the therapist introducing themselves, 
reminding the client of the CM program and the incentive schedule and commenting 
explicitly on the target behaviour (timely attendance). The therapist is expected to 
make an explicit link between the target behaviour and receipt of the incentive and to 
make an appointment for next session, emphasising the importance of attendance and 
linking it with the incentive. For each item adherence is rated from 0-3, representing 
poor, adequate, good and excellent adherence. Scoring judgements are made using 
reference to a manual which I developed in conjunction with Steve Pilling 
(Appendix E). Adequate ratings are typically given when only the core aspect of the 
item is adhered to. Excellent ratings typically reflect all aspects of the model being 
adhered to including in a positive and empathic manner. Total scores are converted 
to a percentage. Adherence levels below 33% are considered poor, over 33% are 
adequate and over 66% are good.  
Client factors 
Socio-demographic and treatment history information 
An interview schedule was administered at baseline. For the current research, 
age, gender, ethnicity and number of previous OST treatments is used.  
Drug use 
Section 2 of the Opiate Treatment Index (OTI) (Darke, Ward, Hall, Heather, 
Wodak, 1991) was used to assess drug use. The OTI consists of a comprehensive, 
standardized set of measures for the evaluation of opiate treatment. For the current 
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research the number of days the client used opiates in the last 30 days is used as an 
indication of severity of drug use. The OTI is designed to measure episodes of drug 
use rather than amount per occasion. This is because reports of ‘average’ use are 
known to under-report consumption (Gregson & Stacey, 1980) and reports based on 
weight and price are influenced by the current market value of the drug and purity 
(Darke, et al 1991). 
Social functioning 
Section 4 of the OTI was used to measure social functioning. This section 
addresses employment, residential stability, inter-personal conflict, social support 
and involvement in drug sub culture. There are 12 items covering these areas. 
Participants indicate the frequency of their difficulties on a scale of 0-4 yielding a 
total score out of 48 for social functioning. A higher score indicates greater 
impairment in social functioning. In addition, the number of times on remand, 
number of times sentenced to prison, and employment status was used as an 
indication of social functioning. 
Motivation 
Treatment Self-Regulation Questionnaire for Drug Abstinence was used to 
assess motivation. Versions of this measure have been validated in other areas of 
addiction and health behaviours (Levesque et al., 2007). For the current study 10 
questions covering the individual’s readiness, confidence, commitment, and the 
importance of reducing and quitting heroin use are rated from 0-10, yielding a total 
score out of 40 for motivation to quit and 40 for motivation to reduce drug use. A 
higher score indicates a higher level of motivation. 
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Attendance 
Attendance is defined as participants attending the scheduled session within 
15 minute of the scheduled time. This is consistent with the definition of timely 
attendance reinforced in the contingency management intervention of the PRAISe 
trial. Total attendance is represented as a proportion of 1, with 1 representing 100% 
attendance of all available sessions. 
Procedure 
Client factor data was collected at baseline before the first treatment session. 
Participants receiving the contingency management intervention completed Agnew 
Relationship Measure-5 (ARM-5) at session four. In four cases the alliance measure 
was completed at a later session due to clinic error or non-attendance at session four. 
Alliance measured at session 5 was used in 3 cases. Alliance measured at session 6 
was used in 1 case. 
I received training in how to use the adherence measures from a principal 
investigator on the trial. I rated session four tapes for participants from the 
contingency management sites. Where session four tapes were not available, due to 
non-attendance or an absence of an audio recording, session 3 tapes were used.  
There were no tapes available for six cases.  
Data analysis strategy 
SPSS statistics package was used for data analysis. First descriptive statistics 
were examined for the independent variables for the whole sample (TAU and CM); 
drug use, treatment history, social functioning, and motivation. Non-parametric tests 
were then used to assess differences in variables between TAU and CM sites. 
Difference in levels of attendance between TAU and CM interventions was assessed 
using a Mann Whitney test to test hypothesis one. 
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Relationships between client factors, therapist alliance, adherence and 
attendance were then investigated in the sample receiving CM interventions. 
Multiple Imputation methods were used to aid this investigation. Multiple 
Imputation is a method used to handle missing data (von Hippel, 2013). Multiple 
imputation uses existing data values in the data set to predict values that are missing. 
These methods have been shown to produce unbiased estimates that are robust to 
violations of assumptions of normality. They have also been shown to be effective 
using small sample sizes and high rates of missing data (Wayman, 2003). SPSS 
automatic multiple imputation method was used.  When using multiple imputation 
methods the process of imputation and analysis is run multiple times. This produces 
multiple databases, in this case five, and a pooled statistic.   
Using the sample that received contingency management interventions 
descriptive statistics were examined for alliance, adherence and attendance. 
Spearman rho correlations were used to investigate relationships between the 
following continuous variables; client factors (age, previous treatment, social 
functioning, prison history, alcohol use, recent drug use, and motivation) alliance, 
adherence and attendance. Kruskal Willis and Mann Whitney tests were used to 
investigate the relationship between categorical client variables (employment, 
gender, ethnicity) and attendance. These tests were examined for a relationship 
between client factors and attendance to test hypothesis two.  To test hypothesis 
three, the relationship between alliance and attendance was investigated using 
Spearman rho correlation and further investigated using a linear regression model. 
Multiple regression analysis was used to investigate the interaction between 
adherence and alliance in predicting attendance. This included terms for linear and 
curvilinear adherence. Using curvilinear adherence allowed for the investigation of a 
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nonlinear relationship, and whether varying levels of adherence interacts with level 
of alliance to predict attendance.  
Results 
Descriptive statistics for whole sample (CM and TAU combined) 
 Means and standard deviations for client factors are presented in table 1. 
Participants reported a high frequency of recent opiate use in the last 30 days and 
80% had received at least one OST treatment previously. Responses on the social 
functioning section of the OTI indicate variation in levels of dysfunction with scores 
ranging from four to 31. 53% of participants reported having been on remand before 
and 57% had received a prison sentence. 92% of the sample was unemployed. 
Average scores on the Motivation and Treatment Self-Regulation Questionnaire 
were high, indicating high levels of importance, readiness, confidence and 
commitment to stop and reduce drug use  
Comparison of CM and TAU sites 
Independent variables 
Shapiro Wilk tests identified that all variables, with the exception of age and 
social functioning were not normally distributed. Mann Whitney and Chi Square 
tests indicated that the distributions of the variables across contingency management 
and TAU groups were not significantly different (Table 2). Due to conducting 
multiple correlations a more stringent significance value of p< .01 is used. 
Interpretations of correlations are guided by Cohen (1998), r=.10 are considered 
small, r=.30 are moderate, and r=.50 are large.
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Table 1 
Client factors for whole sample: means and standard deviations  
  
Mean 
 
Standard Deviation 
   
Previous Treatments 2.55 2.56 
Remand 2.36 3.98 
Prison Sentences 3.10 5.70 
Last 30 days opiate use 25.36 6.07 
OTI Social Functioning 17.68 6.34 
Motivation to reduce drug 
use 
34.68 6.16 
Motivation to stop drug 
use 
35.19 5.19 
OTI=Opiate Treatment Index 
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Table 2 
Comparison of variables across CM and TAU sites 
Variable Statistic 
 
Age 
 
U=600.00, p=.38, r=.01 
Number of previous treatments U= 657.50, p=.80, r=.03 
Number of times on remand U=598.50, p=.59, r=.06 
Number of times prison sentenced U=653.00, p= .74, r=.04 
Recent drug use U=613.50, p=.45,  r=.09 
Motivation to reduce drug use U= 719.00, p=.69, r=.05 
Motivation to stop drug use U=575.50, p=24, p=.13 
Gender X2(1, 76) = .27, p=.77 
Ethnicity X2(12, 76) =11.11, p=.61 
Employment status X2(3, 76)= 3.66, p=.28 
   77 
 
Attendance 
In the CM group average attendance was 77%. In the TAU group average attendance 
was 48%. Mann Whitney test revealed that attendance across the four sessions was 
significantly higher in the contingency management group (mean rank 45.63), than 
the TAU group (26.95), U= 346.50, p= .01, r=0.43, supporting hypothesis 1. 
Analysis of data from CM sample 
The current study used SPSS automatic method to impute values for13 
missing alliance scores and 3 missing adherence scores. Correspondingly values 
were also imputed for 3 missing curvilinear adherence values, 13 missing values 
representing the interactions between linear adherence and alliance and 13 missing 
values representing the interaction between curvilinear adherence and alliance. 
Attendance, alliance and adherence 
On average participants receiving CM attended 77% of sessions (Mean=.77, 
S.D=.30). High levels of alliance were reported (M= 34, S.D. 2.01). This high level 
of alliance and small standard deviation suggests a ceiling effect. Average adherence 
was 41% indicating adequate levels of adherence (Mean= 0.41, S.D 0.15). These 
means and standard deviations are derived from the original sample. Multiple 
Imputation in SPSS methods does not produce a pooled standard deviation. Pooled 
mean levels of alliance were the same as those reported for the original sample to the 
nearest whole number. Pooled levels of adherence were the same as those reported 
for the whole sample to two decimal points.  
Relationships between variables 
Multiple Spearman rho correlations were used to investigate relationships 
between continuous variables (Table 3).Differences in levels of alliance, adherence 
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and attendance based on categorical variables were assessed using Mann Whitney 
and Kruskal Wallis tests (Table 4). There were no differences in alliance, adherence 
or attendance based on categorical variables. There were no significant associations 
between any of the client factors and alliance or adherence. There were no 
significant correlations between client factors and attendance; hypothesis two was 
not supported 
Relationship between alliance and attendance 
A large correlation was found indicating that higher levels of alliance were 
associated with increased attendance, r(45)=.58, p<.0001, supporting hypothesis 
three. As a precautionary measure 3 cases which had standard deviations higher or 
lower than 2.5 were then removed. A correlation for these selected cases produced 
essentially the same results r (42)= .58, p < .0001.  
A linear regression model and standard diagnostic statistics9 were used to 
further investigate the relationships between alliance and attendance. Diagnostic tests 
demonstrated that the assumptions of the regression model had been met and that 
individual cases were not having excessive influence on the model. Although three 
cases had high centred leverage values, Cook’s distance values were acceptable and 
so there was no need to remove these cases from the model (Field, 2009). Alliance 
scores explained a significant proportion of variance in attendance. Using the 
original data, R2 =.32, F (1, 33) = 15.29, p<.001 All imputed models produced R2  
>.21, F > 12 and p <.001. This indicates that alliance accounts for at least 20% of the 
variance in attendance.  A pooled statistic demonstrated that alliance significantly 
predicted attendance B = 0.08, t(46) = 3.60, p<0.001.  This indicates that as alliance 
increases by 1 point, attendance increases 8.3%.  
                                                 
9 Durbin-Watson, Cooks Distance, Centred Leverage and Mahalanobis Distance 
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Table 3  
Correlations between continuous variables 
 Age Previous 
treatment 
Remand Prison  Drug use Social Fx Alliance Adheren-
ce 
Motivati-
on-R 
Motivati-
on-S 
Attendanc
e 
Age 
 
 -.00 .42** .29 -.07 -.08 .03 .19 .28 .32* .10 
Previous 
treatment 
-.00  .19 .30* -.10 -.01 .04 .19 -.03 -.09 -.05 
Remand 
 
.42** .19  .85** -.16 .03 .16 .09 -.03 -.05 .22 
Prison  .29 .30* .85**  -.22 -.02 .15 .14 -.12 -.11 .11 
Drug use -.07 -.10 -.16 -.22  .33* -.10 -.21 -.35* -.27 .22 
Social Fx -.09 -.01 .03 -.02 .33*  -.23 -.14 -.33* -.47** -.09 
Alliance 
 
.03 .04 .16 .15 -.10 -.23  -.18 .22 .29 .58** 
Adherence .19 .19 .09 .14 -.21 -.14 -.18  .07 .01 -.27 
Motivation-R  .28 -.03 -.03 -.12 -.35* -.33* .22 .07 . .86** .22 
Motivation-S  .32* -.09 -.05 -.11 -.27 -.47** .29 .01 .86** . .22 
Attendance .10 -.05 .22 .11 .22 -.09 .58** -.27 .22 .22  
 Remand=Number of times on remand, Previous treatments=Number of previous treatments, Prison =Number of times sentenced to prison, Drug Use= Last 30 days opiate use, Social Fx=Social 
functioning section of Opiate Treatment Index,  Alliance= Agnew Relationship Measure- 5 total, Adherence =  The Adherence Measure for PRAISe Contingency Management Program, 
Attendance=proportion of sessions attended, Motivation R= Motivation to reduce opiate use total of  Treatment Self-Regulation Questionnaire for Drug Abstinence, Motivation S= Motivation to 
stop opiate use total of  Treatment Self-Regulation Questionnaire for Drug Abstinence, *p<.05, **p<.01 
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Table 4 
Differences in alliance, adherence, and attendance based on categorical variables 
 Alliance  Adherence Attendance 
Ethnicity X2(10, N= 34) = 7.60, p=.67 X2(12, N= 44) = 15.78, p=.20 X2(12, N= 47) = 6.14, p=.89 
Employment U= 44.00, p=.30, r=.017 U=41.5 p=.86, r=.03 U= 65.00, p=.24, r= 0.17 
Gender U= 56.00, p=.35, r= .16 U=127.5, p=.61, r=.07 
U=94, p=.037, r=0.34. 
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Relationship between alliance, adherence and attendance 
A multiple linear regression was used to investigate the interaction of alliance with 
both linear and curvilinear adherence predicting attendance. The model was not 
significant for the original data, R2=.05, F (2,31) = .82, p= .45. This indicates that 
neither the interaction between linear adherence and alliance (B= -.03, t (2, 46) = -
.65, p=.53) or the interaction between curvilinear adherence and alliance (B = .02, t 
(2, 46) = .46, p =.65) is associated with attendance. Similarly, none of the imputed 
models were found to be significant. Hypothesis 4 has not been supported. 
Discussion 
This study aimed to investigate the relationship between client factors, 
alliance, adherence and attendance in the first four sessions of a contingency 
management intervention using data from the on-going PRAISe RCT. Participants in 
the current sample reported frequent drug use over the last 30 days, and also 
indicated varying levels of social dysfunction and high levels of motivation to reduce 
and quit illicit opiate use. Variables were equally distributed across CM and TAU 
groups indicating that randomisation was effective and significant findings are 
unlikely to be due to systematic differences between CM and TAU samples. 
Levels of attendance were significantly higher in contingency management 
interventions compared to treatment as usual. This indicates that the contingency 
management interventions are effective in increasing level of attendance to OST. 
CM has previously been found to improve retention in OST (Dutra, Stathopoulou, 
Basden, Leyro, Powers, & Otto, 2008) which is particularly important as retention 
has been shown to be associated with improved outcomes (Zhang et al., 2003).  
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This study did not replicate previous findings of an association between 
alliance and client variables such as social support and motivation. This may be due 
to the ceiling effect found in the measurement of alliance in this trial. Similarly this 
study did not replicate findings of an association between attendance and client 
factors such as social stability, previous treatment and motivation.  This may be due 
to the number of sessions observed. Investigating the relationships between client 
background variables and retention Simpson and Joe (1993) used a sample of 
patients who had completed 2 months treatment. It is possible that an association 
between client factors and attendance may not become apparent until further into 
therapy. 
High levels of alliance were observed in contingency management 
interventions which supports the theoretical position that providing reinforcement 
helps to strengthen the therapeutic alliance. This is particularly important given that 
this client group is considered difficult to engage and that the position of a drug 
therapist may be somewhat different to in other types of therapy. Specifically, the 
educational aspect of a drug therapist’s job, for example highlighting the unwanted 
side effects of continued illicit drug use (Millman, 1986) and sometimes being in the 
position of restricting access to drugs (Carroll, 2005), can be problematic for the 
therapeutic alliance.  
Further investigation revealed that higher levels of alliance were associated 
with increased attendance. This indicates that that having a strong therapeutic 
alliance can further improve attendance in addition to providing an incentive. It 
could be that the alliance has a direct impact on attendance, that alliance itself is a 
positive reinforcer and increases attendance. However, individuals who have 
attended more sessions will also have received more contingency management 
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incentives. It may be that being given more supermarket vouchers by the therapist 
results in a more positive view of the relationship.  
Average levels of adherence were found to be adequate and were not 
associated with any other variables including attendance. This indicates that the level 
of adherence to the CM model does not have an impact on levels of attendance. It is 
of note that even in cases of poor adherence the incentive was appropriately given or 
withheld. It may be that the incentive itself is sufficiently high and rewarding. The 
incentive may constitute the ‘active ingredient’ of the intervention whilst other 
aspects, such as commenting on the date and using explicit verbal praise are less 
important.  
No association was found between adherence and alliance supporting 
previous findings that adherence to a model does not negatively impact on the 
therapeutic alliance (Kember, 2013). There was no interaction between adherence 
and alliance to predict attendance. This is likely to be due, in part, to a ceiling effect 
in alliance. Investigating curvilinear interactions allows explorations of how varying 
levels of adherence may have different relationships with outcome depending on the 
level of alliance. When alliance is uniformly high there is unlikely to be an 
interaction. Previous research suggests that when alliance is high, the level of 
adherence does not impact on outcome  (Barber et al., 2006; Gibbons et al., 2010) 
which could be being reflected in the results of this study.  
Limitations 
The current study is limited by a small sample size. Power analysis indicated 
that the sample size was not sufficient to detect the expected effect size regarding the 
interaction between curvilinear adherence and alliance predicting attendance. 
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Relationships between the variables of interest may be detected using a larger 
sample. The current study is also limited as it only uses data from the first four 
sessions of an intervention.  The findings reported may not generalise or be 
applicable later in therapy. Furthermore relationships between the variables of 
interest may not become apparent until later in therapy.  
As alliance and adherence were measured at session four and attendance 
measured across therapy no inferences about causal relationships can be made. 
Furthermore adherence and alliance is measured at a single time point which may 
not be representative of the level of these variables across the course of therapy. 
There is also the question of what exactly is being measured with regard to 
alliance and adherence. Although frequently cited, the term alliance can be 
understood in different ways and commonly used measures of alliance are reported 
to have less than 50% shared variance (Horvath, et al., 2011). Furthermore the 
uniformly high levels of alliance indicate a ceiling effect which restricts the 
exploration of its relationship with other variables. With regard to the ‘active 
ingredients’ and adherence to the CM intervention, there may also be other 
unmeasured therapeutic techniques involved in the key work session that are 
impacting on outcome. It is also important to consider the relevance of attendance as 
an outcome. Although it is important to address the high attrition and lack of 
attendance in OST, the key outcome in any therapy for substance use disorders is 
reduced illicit drug use which has not been addressed in the current study.  
Future research 
Future research should address the issue of power using a greater number of 
participants. Using a longer period of therapy with multiple measures of alliance and 
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adherence will provide an opportunity to see if a relationship between client factors, 
adherence, alliance and outcome develop over the course of therapy. This will also 
provide information on the temporal relationship between variables and allow 
inferences about causality to be made. 
Future research should investigate the relationship between attendance and a 
reduction in illicit drug use in contingency management interventions. Furthermore 
research should investigate the relationship between the variables of interest in the 
current study with reduced illicit drug use as the primary outcome measure. It is of 
note that when completed, the full PRAISe dataset will be able to address these 
limitations. 
Finally although the ARM 5 has acceptable psychometric properties and 
converges with the full ARM (Cahill et al., 2011), future research should consider 
using the full arm in order to maximise the opportunity to detect variability in levels 
of alliance and avoid a ceiling effect. A further alternative would be to use an 
observer measure of the alliance, although this is of course more labour intensive.  
Conclusion 
This study demonstrates that contingency management interventions are 
efficient in increasing attendance in OST over the first four sessions of therapy. 
Previous findings of an association between client factors and attendance were not 
replicated in the current study. It is suggested that this is due to differences in 
measurement and the length of treatment being considered. Alliance was found to 
have a significant association with increased attendance. It is suggested that observed 
high levels of alliance are a result of increased attendance and receipt of incentives. 
The previous finding of an interaction between adherence and alliance predicting 
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outcome was not replicated in the current study. It is suggested that this is due to 
sample size and a ceiling effect in alliance. It could also be that levels of adherence 
do not impact on outcome in conditions of high alliance as has been demonstrated in 
previous research.  It is argued that the results indicate the basic fundamental part of 
the CM intervention- the incentive- promotes the therapeutic alliance and is 
sufficiently high and rewarding to increase attendance. Future research should aim to 
address the identified limitations, and in particular investigate the relationship 
between alliance, adherence and attendance over a longer period of therapy using 
measurements at multiple time points and reduction in illicit drug use as an outcome. 
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Part 3: Critical Appraisal 
 
Limitations of common and specific factors research and 
the ethical and moral considerations of using incentives in 
healthcare 
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Introduction 
The literature review and empirical paper focus on the relationship between 
common factors such as the therapeutic alliance, and specific factors such as 
adherence, in relation to therapeutic outcome. Despite this focus there has been little 
opportunity to explore the debate between common and specific factors in the 
psychotherapy literature (DeRubeis, Brotman & Gibbons, 2005; Messer & 
Wampold, 2002). The first section of this critical appraisal highlights some of the 
key limitations of the research into alliance as a common factor, and specific factors 
as measured by adherence. 
Another area relevant to the empirical paper is the ethical and moral 
considerations of using incentives in health care. The second section of this critical 
appraisal offers a brief description of some of the concerns about contingency 
management (CM) and some of the implications for research and clinical practice are 
discussed. 
Section 1: Common and specific factors 
Section 1 will first consider some of the limitations of the ‘common factors’ 
research. Common factors are those variables that are present in more than one form 
of therapy (Castonguay, 1993) for example the therapeutic alliance, a healing setting 
and education. This section will focus in particular on the therapeutic alliance. The 
way in which study design can affect results will be highlighted. It is stressed that 
caution should be exercised when making generalisations about the relationship 
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between common factors and outcome from one type of therapy or patient group to 
another. 
Next, research into ‘specific factors’ will be considered. Specific factors are 
those variables that represent techniques used by a therapist (Castonguay, 1993). 
Castonguay and Holtforth (2005) explain further that the term specific factors refer 
to theory specific techniques prescribed for a particular therapy. The limitations in 
the literature and difficulty with implementing research into this area are highlighted, 
which it is argued could account for the lack of consistent findings regarding the 
relationship between specific factors and outcome. 
Common factors 
DeRubeis et al. (2005) describe how numerous findings have been used to 
support the claim that benefits of psychotherapies can be attributed to common 
factors. In particular, Luborsky’s (2002) meta-analysis finding equivalent outcomes 
from different psychotherapies has led to the conclusion that common factors are 
responsible for clinical improvement. Considering common factors such as placebo 
effects, working alliance, and therapist allegiance, Messer and Wampold (2002) 
conclude that such factors account for a much larger proportion of variance in 
outcome than specific factors.  
DeRubeis et al. (2005) argue that the specific effects of psychotherapies may 
be substantially stronger than is widely believed. The authors go on to suggest that it 
is entirely possible that two treatments each work by specific and different means to 
effect outcome, resulting in equivalent benefit. Findings of equivalence may also be 
due to studies comparing active treatments to control groups using small samples, 
and therefore being underpowered (Jensen, Weersing, Hoagwood, & Goldman, 
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2005). There are methodological criticisms of studies that report findings of 
equivalence, such as problems associated with using meta-analyses, and issues of 
measurement, which call into question the conclusions that are made about common 
factors. 
Beutler (2002) criticises Luborsky’s (2002) analysis, which is based on 
collapsing 100 different types of patient into one group and 400 types of 
psychotherapy into six groups. Beutler (1979) questions the legitimacy of collapsing 
groups in this way as it assumes uniformity of patients and therapies. Such analysis 
does not allow for consideration that personality and pathology characteristics may 
determine response to treatment. Beutler (2002) identifies that patients with different 
diagnoses respond differently to different treatments. For example, particular 
therapies are associated with positive outcome for specific anxiety disorders whilst 
patients with depression respond similarly to many different treatments. Beutler 
(2002) notes that the Luborsky analysis is heavily loaded with depression studies 
which could have affected the results. Similarly Beutler (2002) criticises the 
assumption that theoretically similar therapies (on which Luborsky’s categorisation 
is based) are functionally similar and that this assumption does not allow for 
consideration of differential effects of functionally different therapies.  
Beutler (1979) presents an analysis that divided patients by personality, 
problem complexity and severity, and divided treatments into groups of procedures. 
This analysis found a number of differential effects of treatment. For example, 
Beutler (1979) found insight therapy to be more effective than behavioural therapy 
for patients who were highly ‘reactive’. The term ‘reactive’ describes patients who 
are likely to resist external influences to their autonomy. Behavioural therapy was 
found to be more effective than insight therapy in patients who were less ‘reactive’.  
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Beutler’s (1979; 2002) comments illustrate the difficulties with interpreting 
the results from meta-analyses on which the evidence for common factors, 
particularly the alliance, is largely based on. Horvath and colleagues (Horvath & 
Bedi, 2002; Horvath, Del Re, Fluckiger, & Symonds 2011; Horvath & Symonds, 
1991) meta-analyses are frequently cited as demonstrating the impact of alliance 
across psychotherapies. However, meta-analyses can over simplify matters relying 
on arbitrary decisions about categories. These decisions about categories and study 
selection procedures can introduce bias (Ehlers et al., 2010) which Beutler (2002) 
has demonstrated can significantly affect the results and conclusions made.  
There are further methodological considerations when interpreting results 
from meta-analyses. In particular, concluding equivalence from different comparison 
studies reporting no difference can be misleading. Comparisons of two effective 
therapies may find a null result. Similarly comparisons of two ineffective therapies 
may find a null result. This of course does not mean that the findings of no 
difference in both such comparison studies indicate that all therapies are equivalently 
effective (Ehlers et al., 2010). 
DeRubeis et al. (2005) highlight further difficulties when using meta-
analyses, criticising the Horvath et al. (2011) meta-analysis stating that because it 
included studies that involved interventions from a variety of orientations, the 
relationship between alliance and outcome in specific types of therapy had not been 
addressed. Consistent with this criticism, studies that focus on the alliance-outcome 
relationship in a specific therapy have yielded inconsistent results. This 
inconsistency has led to the argument that the influence of alliance on outcome may 
in fact be different across different types of therapy (Gaston, Thompson, Gallagher, 
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Cournoyer, & Gagnon, 1998; Safran & Wallner, 1991 as cited in DeRubeis et al., 
2005).  
In addition to the problems identified when using meta-analysis (i.e. 
problems with defining categories, comparison studies of effective therapies 
producing null results, and relationships between alliance and specific types of 
therapy being neglected) it is of note that the correlations reported by meta-analyses 
investigating the relationship between alliance and outcome are small (DeRubeis et 
al. 2005). This not only raises questions about the strength of the association 
between alliance and outcome but also the question of what else is responsible for 
therapeutic improvement. 
There are also general limitations in the alliance-outcome research literature 
which meta-analyses draw on. Alliance is usually assessed during treatment and then 
correlated with pre-treatment and post treatment scores. Therefore, alliance-outcome 
correlations could be due to the influence of prior symptom change on the quality of 
alliance (Webb, Auerbach, & DeRubeis. 2012). Furthermore as Horvath et al. (2011) 
notes, the ambiguity of the definition of alliance has consequences for the tools 
developed to measure it. The Horvath et al. (2011) meta-analysis is based on studies 
that use over 30 different measures of alliance. Although two thirds of the papers use 
‘4 core measures’, as mentioned in the literature review, even these have a shared 
variance of less than 50% indicating that they are measuring somewhat different 
constructs. Horvath et al. (2011) emphasises that what is known of the relationship 
between alliance and outcome is based on the diverse instruments used to measure it. 
Given these limitations it is suggested that one should be cautious when interpreting 
results from studies into common factors such as the alliance 
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Specific factors 
The degree to which therapists are delivering theory specific techniques in 
the manner that they were intended is referred to as therapist adherence. Research 
investigating the impact of specific factors considers correlations between levels of 
adherence and outcome in psychotherapy. Webb, DeRubeis and Barber (2010) 
conducted a meta-analysis and conclude that adherence has little impact on outcome. 
However there are a number of factors that should be considered with regard to such 
findings.  
 Firstly, the Webb et al. (2010) meta-analysis included studies that involved a 
variety of interventions in numerous contexts. It is possible that adherence is related 
to outcome in some contexts, but not others. Therefore it may not be sensible to 
conduct a meta-analysis which aggregates effect sizes of these different studies. 
Similar to the criticism of common factors research, one should exercise caution 
when making generalisation about the relationship between theory specific 
interventions and outcomes from one type of therapy or patient group to another. 
There are a number of limitations in the research that Webb et al. (2010) 
draws on that should be considered when making conclusions about the results. 
Ratings of adherence are usually collected early in treatment and correlated with 
outcomes collected a considerable amount of time later. Therefore, any relationship 
between adherence and outcome may be overshadowed by processes that occur 
between measurement of adherence and measurement of outcome (Webb et al., 
2010).   
Another issue is that often analysis investigating the relationship between 
adherence and outcome is based on mean scores. It may be that particular 
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interventions captured by the measures are associated with improved outcome, 
whilst others are not. Such associations would not be detected by using a mean score 
(Webb et al., 2012). This is extremely important. Measures of adherence often 
include a number of items reflecting a variety of interventions within a therapeutic 
modality. Not only will a mean score fail to detect associations between a specific 
intervention and outcome, there are also likely to be other theory specific 
interventions being used that are not being measured but are having an impact on 
outcome. Therefore making conclusions about the relationship between a particular 
type of therapy and outcome based on adherence scores may be misleading and 
should be restricted to only the particular theory specific technique being measured. 
This is particularly relevant given that several techniques have been identified as 
common to many approaches (Castonguay & Holtforth, 2005), for example goal 
setting and providing a formulation.  
It is emphasised that there is a relative lack of research into the impact of 
specific factors and the adherence-outcome relationship. For example, Webb et al 
(2010) found no previous meta-analyses investigating the adherence outcome 
relationship whilst there are many meta-analyses focusing on the alliance-outcome 
relationship cited above. The lack of research investigating adherence-outcome 
relationships may be partly attributable to the focus on investigations into common 
factors, rather than specific interventions, fuelled by the dodo bird verdict (Webb et 
al., 2010). In addition, techniques required to gather adherence data, such as rating 
tapes of therapy sessions, are more labour intensive than self-report techniques 
employed to collect data on therapeutic alliance.  
Another factor that is important to consider is that studies that collect 
adherence data also often take care to train therapists in the intervention being 
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investigated resulting in high levels of adherence with little variability. This high 
level and restricted range would result in smaller effect sizes than would be expected 
to be observed from a broader population of therapists. 
It is suggested that one should be cautious when making generalisations 
about the association between specific factors and outcome based on adherence-
outcome studies. This suggestion is based on the limitations in the research and the 
fact that measures of adherence will fail to measure all specific factors that may be 
associated with outcome  
Conclusion and recommendations 
Section 1 of this critical appraisal suggests that the limitations regarding the 
use of meta-analyses, the methodological limitations of studies investigating 
common factors, and issues of measurement mean caution should be exercised when 
considering research findings regarding common factors such as alliance. It is likely 
that alliance has a different relationship with outcome in different types of therapy 
with different types of patients. This has implications for future research. It is 
important that effectiveness studies continue to incorporate measures of alliance into 
study design. This will help to develop the understanding of the relationship between 
alliance and outcome using different types of therapy with different groups of 
patients. However, this appraisal also indicates that there is significant variation in 
how alliance is conceptualised and measured. Hovarth (2006) states that there is a 
need for clarification on the elements that make up the therapeutic alliance. Until 
such clarification is achieved it is difficult to give recommendations, guidance or 
training to a therapist with regard to the therapeutic alliance (Horvath , 2004 as cited 
in Horvath, 2006). Therefore whilst the debate continues as to what constitutes the 
therapeutic alliance, researchers may wish to examine the measure of alliance used 
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more closely to consider what aspects of the ‘alliance’ are being assessed, and how 
these specific aspects relate to outcome.  
With regard to specific factors this critical appraisal argues that although 
research does not consistently report an association between adherence and outcome 
there are a number of methodological limitations that should be considered when 
interpreting such findings. A particular limitation is that in any given therapy there 
are likely to be unmeasured specific factors that could be contributing to outcome 
that are not detected by the measure of adherence. Future research should therefore 
continue to incorporate measures of adherence to advance the understanding of how 
theory specific interventions contribute to outcome in different therapies and 
different patient groups. Finally given the ambiguity in the definition of alliance and 
limitations of the measures of adherence, researchers should be cautious when 
making generalisations from their findings about ‘adherence’ and ‘alliance’. It is also 
noted that delineating the active components of treatment, whether they be common 
or specific factors, is a complicated process. As Horvath (2006) suggests, it may be 
that “the concept of treatment is too high a level of aggregation to serve as a 
discriminatory notion to determine what is effective in therapy” (pp. 261). 
Section 2: Ethical and Moral Considerations of 
Contingency Management  
This section focuses on some of the moral and ethical concerns about the use 
of health incentives and contingency management (CM) interventions. How these 
concerns impact on clinician’s views and the adoption of CM into clinical practice is 
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considered. It is suggested that it is important to consider these factors when 
designing a clinical trial and attempting to implement CM interventions.  
CM interventions in substance use are typically implemented to retain service 
users in treatment and to foster drug abstinence. CM interventions involve 
identification of a target behaviour such as abstinence which is reinforced with an 
incentive when it occurs, and the incentive is withheld when the target behaviour 
does not occur (Petry, 2006). Often a voucher such as that used in the PRAISe trial 
detailed in the empirical paper, is used as an incentive.  
A commonly cited concern regarding the use of incentives in health care is 
that it is coercive, paternalistic and infringes on an individual’s autonomy (Halpern, 
Madison & Volpp, 2009). Such an argument has ramifications for the ethics of 
implementing CM in a health care setting such as the NHS. These arguments may 
also affect a clinician’s attitudes to CM and its incorporation into clinical practice.  
Concerns are also expressed that CM interventions discriminate against the 
poorest and most vulnerable in society. Interestingly, high rates of taxation on 
cigarettes, which can be considered as a disincentive and punitive, and arguably 
disproportionately affect the poorest, have been accepted by society. Halpern et al. 
(2009) emphasise that incentive programs differ from disincentive interventions in 
that they offer more support to the disadvantaged and promote wellbeing.  
Halpern et al. (2009) argues that the use of incentives rather than being 
coercive can in fact be considered an example of libertarian paternalism. This is the 
idea that private and public institutions encourage people to make decisions that will 
improve their lives without restricting freedom of choice. Thaler and Sunstein (2003) 
state that it is inevitable that organisations make decisions and take action that will 
104 
 
impact on people’s choices. Examples of such decisions range from implementing an 
opt out organ donor scheme, to removing unhealthy food and snacks from school 
cafeterias. Thaler and Sustein (2003) suggest that taking actions that impact on 
people’s choices does not necessarily equate to coercion. Individuals will often make 
choices that they would not make if they had full information, no restriction on their 
cognitive abilities and sufficient will power (Thaler & Sunstein, 2003). Libertarian 
paternalism and providing an incentive does not limit the choices or options 
available to the individual. Instead it helps guide them to towards making better 
choices, as judged as better by themselves (Halpern et al., 2009). Halpern et al. 
(2009) develops this argument explaining that people possess varying degrees of 
ability to change their behaviours that impact on their health. These abilities are 
affected by environmental, economic and genetic factors, and society has a 
responsibility to help people who encounter such barriers.  
In other areas where libertarian paternalism is exercised, involving a change 
of the ‘default’ position, for example changing an organ donation system from opt in 
to opt out (as will be implemented in Wales in 2015) one could argue that an 
individual’s freedom of choice is being restricted as decisions are not consciously 
thought through (Rajan, 2012).  This critical appraisal suggests that the same 
argument is not as applicable in the case of CM for opiate users in the PRAISe trial . 
Participants in the PRAISe trail are voluntarily attending an Opiate Substitution 
Treatment (OST), which has an explicit aim of reducing illicit drug use. Therefore, 
the accepted goal of reducing illicit opiate use has been consciously considered by 
the individual and CM supports them in reaching this goal, rather than being 
coercive.  
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Clinicians can hold ethical concerns and negative views about  CM which  
can effect the uptake of CM (Sinclair, Burton, Ashcroft & Priebe, 2011). Kirby, 
Benishek, Dugosh and Kerwin, (2006) identifies a concern amongst clinicians that 
CM does not address the underlying issues that lead to drug addiction.  Rash, Petry, 
Kirby, Martino, Roll, and Stitzer, (2012) conducted a web based study to develop a 
measure assessing beliefs about CM and to examine the relation of these beliefs to 
clinician characteristics. The authors identified a number of other commonly held 
negative beliefs about CM that could affect its uptake. These included the cost of the 
intervention and a concern about what happens after the withdrawal of the incentive. 
Rash et al. (2012) also highlight an attitude that the empirical basis of CM is not 
relevant to everyday clinical populations. Attitudes toward treatment manuals, 
evidence based practice (Henggeler et al., 2008) and traditional views about 
treatment can be barriers to the adoption of a new treatment like CM (McCarty et al. 
2007). Another concern held by clinicians is that patients will use the incentive 
gained to obtain more drugs (Petry, 2006), although research suggests that when 
participants receive incentives during drug abuse research they are able to use these 
payments in a responsible and safe manner (Festinger et al. 2005). 
Rash et al. (2012) states that the sorts of negative beliefs described above 
reflect a limited understanding of CM. Cameron and Ritter (2007) surveyed drug 
practitioners and found that their attitudes were based on a cursory understanding of 
CM. Practitioners often used an over-inclusive definition of CM that involved 
providing positive reinforcement on an ad hoc basis as opposed to on a structured 
contractual basis.  
Roll, Madden, Rawson, and Petry, (2009) identified that a lack of familiarity 
with CM and its empirical support may affect its uptake . Cameron and Ritter (2007) 
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found that practitioners in their study changed their ideas about CM over the course 
of the study as a result of being provided with written information. Similarly Rash et 
al. (2012) identified that having received training in CM was associated with less 
endorsement of barriers to the uptake of CM. These findings indicate that providing 
information and training is vital to address clinician’s understanding of CM which 
can affect their attitudes and perspectives and likelihood of using CM. 
Conclusions and recommendations 
It is argued in section 2 of this critical appraisal that the use of CM 
interventions in substance misuse can be considered libertarian paternalism as 
opposed to coercion. These interventions serve to offer more support to the 
disadvantaged and to promote their wellbeing, and help people to reach their own 
goals.  
The literature reviewed above identified that clinicians may have concerns 
regarding CM; e.g. what will happen when the incentive is withdrawn, what the 
incentive may be used for, that it may not address the underlying issues causing drug 
addiction and that it is coercive. The literature suggests that negative views held by 
clinicians may be due to a cursory understanding and that providing information and 
training can effect clinicians attitudes and their likelihood of using CM. This has 
implications for clinical research investigating the use of incentives. It may be 
important to survey therapists involved in a clinical trial on their attitudes towards 
CM. Negative attitudes could have an impact on their adherence to the CM model 
and could also influence the therapeutic alliance. As the research shows that a 
cursory understanding of CM can lead to negative views of CM, it is important that 
therapists receive sufficient training, information and on-going supervision to 
address the perceived barriers to using CM. It is likely that participants may also 
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hold negative views about CM. Providing therapists with a comprehensive 
understanding of the principles of CM may empower them to communicate this 
understanding to participants as necessary, and increase participants’ motivation to 
engage with the program. 
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Appendix A: Inter rater reliability information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Inter Rater Information 
 
Study 
 
Inter- rate reliability information 
Strunk et al. (2010) 
 
2 trained raters rated all sessions. * 
Webb, et al. (2012b) 3rd  session randomly assigned to 5 trained raters. Each tape rated 
independently by 2 raters. * 
 
Minonne (2008) 8 trained raters were used to rate adherence. 4 videotapes per patient 
were rated, 2 from sessions early in treatment and 2 from sessions late 
in treatment. 2 raters rated each tape. ***  
 
Castonguay et al.s (1996 4 Trained raters. A random tape was selected from first half of therapy 
and rated by 3 raters.  * 
 
Strunk,et al. (2012) 
 
50 Trained raters. First 3 sessions rated by 4 independent raters. * 
Gaston and Ring (1992 
 
Sessions 5, 10, and 15 independently rated by two raters.* 
Gaston et al. (1998) Sessions 5, 10, and 15 independently rated by two raters. * Therapist 
Understanding Subscale rater agreement ranged from fair to moderate. 
 
Bambling et al. (2006) 2 raters rated tapes for PST adherence. *** 
  
Carroll et al. (1997) 5 experienced and trained clinicians blind to therapy condition rated an 
early session rated * 
 
  
Hogue et al. (2008b) 7 trained raters for CBT, and 8 for MDFT were used. 2 judges rated 
each tape. First two sessions of therapy and 3 consecutive  tapes from 
session 6. *** 
1 random early session and one late session was coded for alliance. For 
CBT 71 sessions across 47 cases were coded. For MDFT 73 sessions 
across 67 cases were coded. 
 
Gibbons et al. (2010) 8 trained raters rated all available sessions from 163 patients for 
adherence. 9 randomly selected sessions rated by all 8 raters indicated 
almost perfect agreement  
between raters 
 
 
Barber et al. (2008) For SET adherence 2 raters, expert in SET rated one randomly selected 
session between sessions 2-10, for each patient. ** 
For IDC adherence two experts rated a sample of 54 tapes from 37 
patients. * 
 
Barber et al. (2006) 2 raters, expert in IDC rated a random session between 2-10, for each 
patient** 
 
  
Evans-Jones et al. (2009) Adherence measures completed by therapist, typically rated at session 
6.        
 
Goldman and Gregory 
 
 
 
1 trained rater and 1 expert independently rated adherence *** and 
alliance** assessed at 5 time points across therapy 
  
Ogrodniczuk, & Piper (1999) 
 
 
10 trained raters were used. 9 sessions for each patient rated for 
Interpretive * & Supportive*** adherence by all raters. 
Gaston et al. (1994) Trained Experienced psychotherapists Data on alliance and adherence 
from 3 sessions across the course of therapy was collected by two 
teams of 3 raters. *** 
 
Pavio et al. (1994) Trained raters assessed adherence in a random sample of segments 
from randomly selected  early, middle and late sessions. Authors report 
‘good’ rater reliability based random sample. Alliance data collected at 
end of each session 
 
Liber et al. (2010) 8 trained raters used. 104 randomly selected sessions sampled from 
early and late sessions were coded for alliance*** and adherence* 
 
Loeb et al. (2005) Doctoral level Clinical Psychology Students rated sessions 6, 12, and 
18 for adherence and alliance. One rater per tape.  Rater reliability 
based on sample of 24 tapes *** 
 
*     Interclass coefficient indicate moderate to strong agreement between raters. **   Inter class coefficient indicate strong agreement between raters.*** Inter class 
coefficient indicate almost perfect agreement between raters. 
 
 
  
Appendix B: Adherence, alliance and outcome measures 
 
Alliance Measures 
California Psychotherapy Alliance Scales  
Marmar, C.R., Weiss, D.S., Gaston, L. (1989). Towards the validation of the 
 California Therapeutic Alliance Rating System. Journal of Consulting and 
 Clinical Psychology, 1, 46-52. 
Helping Alliance Questionnaire 
Luborsky, L., Barber, J. P., Siqueland, L., Johnson, S., Najavits, L. M., Frank, A. 
 (1996). The revised helping alliance questionnaire (HAq-II): Psychometric 
 properties. Journal of Psychotherapy. Practice and Research , 5, 260-271. 
The Therapy Process Observational Coding System for Child Psychotherapy–
Alliance scale 
McLeod, B. D. (2005). Therapy process observational coding system for child 
 psychotherapy – alliance scale. Unpublished coding manual prepared at 
 Virginia Commonwealth University. 
 Vanderbilt Therapeutic Alliance Scale 
Hartley, D.E., & Strupp, H.H. (1983). The therapeutic alliance: Its relationship to 
 outcome in brief psychotherapy. In J. Masling (Ed.), Empirical studies of 
 psychoanalytical theories (Vol. 1). Hillsdale, NJ: Erlbaum. 
Working Alliance Inventory 
Horvath,A.O.,& Greenberg,L.S.(1989). Development and validation of the working 
 alliance inventory. Journal of Counselling Psychology, 2, 223-233. 
  
Adherence Measures 
Adherence/Competence Scale for Supportive Expressive Therapy for cocaine 
dependence 
Barber, J. P., & Crits-Christoph, P. (1996). Development of an 
 adherence/competence scale for dynamic therapy: Preliminary findings. 
 Psychotherapy Research, 6, 81-94. 
Adherence/Competence Scale for Individual Drug Counselling 
Barber, J. P., Mercer, D., Krakauer, I., & Calvo, N. (1996). Development of an 
 adherence/Competence Rating Scale for individual drug counselling. Drug 
 and Alcohol Dependence , 43, 125-132. 
The Australian treatment adherence protocol for the FRIENDS treatment 
 Barrett, P. M. (1999). FRIENDS Support Material. Unpublished manuscript. 
 Australia: Queensland. 
Collaborative Study Psychotherapy Rating Scale 
 Hill, C.E., O’Grady, K.E., Elkin, I. (1992). Applying the Collaborative Study 
 Psychotherapy Rating Scale to rate therapist adherence in cognitive-behavior 
 therapy, interpersonal therapy and clinical management. Journal of 
 Consulting and Clinical Psychology, 60, 73-79. 
The Coding System of Therapist Feedback  
Goldfried, M. R., Newman, C. N., & Hayes, A. M. (1989). The coding system of 
 therapeutic focus. Unpublished training manual, State University of New 
 York at Stony Brook. 
 
 
  
Emotion Focused Therapy Adherence Checklist 
Paivio, S. C., & Nieuwenhuis, J. A. (2001). Efficacy of emotion focused therapy for 
 adult survivors of childhood abuse: A preliminary study. Journal of 
 Traumatic Stress, 14, 115–134. 
Interpretive and Supportive Techniques Scale 
Ogrodniczuk, J.S., & Piper, W.E. (1999). Measuring therapist technique in 
 psychodynamic psychotherapies. Journal of Psychotherapy Practice and 
 Research, 8, 142-154. 
Inventory of Therapeutic Strategies 
Gaston, L., & Ring, J. M. (1992). Preliminary results on the Inventory of Therapeutic 
 Strategies (ITS). Journal of Psychotherapy Research and Practice, 1, 1-13. 
Measure of ‘working relationship’. Therapist self report.  
Ogrodniczuk, J.S., & Piper, W.E. (1999). Measuring therapist technique in 
 psychodynamic psychotherapies. Journal of Psychotherapy Practice and 
 Research, 8, 142-154. 
The Minnesota Therapy Rating Scale 
DeRubeis, R. J., Hollon, S. D., Evans, S. D., Evans, M. D., & Bemis, K. M. (1982). 
 Can psychotherapies for depression be discriminated? A systematic 
 investigation of cognitive therapy and interpersonal therapy. Journal of 
 Consulting and Clinical Psychology, 50, 744–756. 
Problem Solving Therapy Adherence Scale 
Bambling, M., King, R., Raue, P., Schweitzer, R., & Lambert, W. (2006). Clinical 
 supervision: its influence on client-rated working alliance and client symptom 
  
 reduction in the brief treatment of major depression. Psychotherapy 
 Research, 16, 317-331. 
Therapist Behaviour Rating Scale 
Diamond, G. S., & Diamond, G. M. (2002). Studying a matrix of change 
 mechanisms: An agenda for family-based process research. In H. A. Liddle, 
 D. A. Santisteban, R. F. Levant, & J. H. Bray (Eds.), Family psychology: 
 Science-based interventions. Washington, DC: American Psychological 
Association. 
The Therapy Rating Scale 
Wagner, E. F., Frank, E., & Steiner, S. C. (1992). Discriminating maintenance 
 treatments for recurrent depression: Development and implementation of a 
 rating scale. Journal of  Psychotherapy Practice and Research, 1, 280–290. 
Yale Adherence and Competence Rating Scale  
Carroll K. M., Nich C., Sifry R., Frankforter T., Nuro K. F.,Ball S. A. (2007). A 
 general system for evaluating therapist adherence and competence in 
 psychotherapy research  in the addictions. Drug Alcohol Dependence, 57,  
 225–38. 
Outcome Measures 
Addiction Severity Index 
McLellan A. T., Kushner H., Metzger D., Peters R., Smith I., & Grissom G (1992). 
 The fifth edition of the Addiction Severity Index. Journal of  Substance 
 Abuse Treatment,  9, 199–213. 
  
Becks Depression Inventory 
Beck, A. T., Steer, R. A. and Brown, G. K. (1996). Beck depression inventory-II: 
 Manual. San Antonio: The Psychological Corporation. 
Hamilton Depression Rating Scale 
Hamilton, M. (1960). A rating scale for depression. Journal of Neurological and 
 Neurosurgical Psychiatry, 23, 56-61. 
Interpersonal Behaviour Scale 
Piper, W. E., Debbane, E. G., & Garant, J. (1977). An outcome study of group 
 psychotherapy. Archives of General Psychiatry, 34, 264-274. 
Psychiatric Status Schedule 
Spitzer, R. L., Endicott, J. E., & Cohen, G. M. (1967). Psychiatric status schedule. 
 New York: New York State Department of Mental Hygiene. 
Structured Clinical Interview for DSM  
First M. B., Spitzer R. L., Gibbon M.,Williams J. B.W. (1995). Structured Clinical 
 Interview for DSM-IV, Patient Edition.Washington, DC: American 
 Psychiatric Press; 
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Appendix D:Adherence Measure for PRAISE contingency 
management program: abstinence and attendance versions. 
 
 
  
Adherence Measure for PRAISe Contingency Management Programme- ATTENDANCE 
Rating to be made on basis of an audio recording 
Please place an X in the box that best describes the nature of the interaction 
 Poor 
0 
Adequate  
1 
Good 
2 
Excellent 
3 
1. Introduced self and put client at 
ease 
No introduction and no 
general inquiry 
Limited introduction 
and limited general 
inquiry 
Clear introduction and 
general inquiry 
Full and clear Introduction and 
general inquiry 
2. Described the purpose of the CM 
intervention  
No description of the 
intervention 
Limited description of 
the intervention 
Full  description of the 
intervention and few, if 
any, elements missing  
Full  and positive description of 
the intervention, no  element 
missing 
3. Checked service users 
understanding and answered any 
questions 
No attempt to check  
service users 
understanding or answer 
questions 
Attempt to check  
service users 
understanding but 
no/limited  answer to  
questions 
Good check of 
understanding and 
questions fully 
addressed 
Excellent check of 
understanding and questions 
fully addressed in a very 
positive manner   
4. Relevant incentive schedule clearly 
specified: 
 
No schedule set out 
 
 
Schedule set out but 
limited link between 
incentive and 
attending at the 
agreed date and time 
Schedule clearly set out 
and clear explicit link 
made between 
incentive and attending 
at the agreed date and 
time 
Positive and encouraging 
manner. Schedule clearly set 
out and clear explicit link made 
between incentive and 
attending at the agreed date & 
time 
  
ITEMS 5 and 6 to be completed when Incentive HAS been given 
5. Comments positively on clients 
attendance at correct time 
 
Score this item double 
No comment on 
attendance at correct 
time- date or time 
 
Limited comment on 
attendance at correct 
time-specifying time  
or date 
Clear comment on 
attendance at correct 
time AND date 
 
Clear and positive comment on 
attendance at correct time AND 
date 
6.Gives the incentive and clearly 
states in positive manner it is for 
attending on time 
 
Incentive not given 
 
Gives Incentive with 
limited comment on 
link to attendance 
 
Gives incentive with 
clear comment on link 
to attendance 
Gives incentive and offers 
praise with clear comment in a 
positive tone on attendance. 
 
ITEMS 7 and 8 to be completed when Incentive HAS NOT been given 
7. Commented in a neutral manner 
on service user’s attendance at 
incorrect time 
 
Punitive tone with or 
without comment on 
service user attendance  
at incorrect time 
 
Limited comment on 
service user 
attendance at 
incorrect time 
 
Neutral tone. Clear 
comment on service 
user attendance at 
incorrect time 
Neutral tone. Clear comment on 
service user attendance at 
incorrect time.  Comment to 
shape future behaviour. 
8. Withholds the incentive and 
clearly states  this is due to the client 
not attending  at the correct time  
Incentive given 
Or 
Punitive Tone. Incentive 
not given and no link to 
attendance  at incorrect 
time 
Incentive not given 
with limited link to 
attendance at 
incorrect time 
Incentive not given with 
clear comment on link 
to attendance at 
incorrect time 
 
Incentive not given with clear 
comment on link to attendance 
at incorrect time. Praise 
attendance although at 
incorrect time. 
  
 
 
 
9. Agrees the day/date of the next 
test session 
 
No time given 
 
 
Time given and clearly 
specified 
 
Time given and clearly 
specified – importance 
of attendance 
emphasized 
Time given and clearly specified 
– importance of attendance and 
incentive emphasised in a 
positive manner  
  
Adherence Measure for PRAISe Contingency Management Programme- ABSTINENCE 
Rating to be made on basis of an audio recording. 
Please place an X in the box that best describes the nature of the interaction 
 Poor 
0 
Adequate  
1 
Good 
2 
Excellent 
3 
1. Introduced self and put client at 
ease 
No introduction and no 
general inquiry 
Limited introduction 
and limited general 
inquiry 
Clear introduction and 
general inquiry 
Full and clear Introduction and 
general inquiry 
2. Described the purpose of the CM 
intervention  
No description of the 
intervention 
Limited description of 
the intervention 
Full  description of the 
intervention and few, if 
any, elements missing  
Full  and positive description of 
the intervention, no  element 
missing 
3. Checked service users 
understanding and answered any 
questions 
No attempt to check  
service users 
understanding or answer 
questions 
Attempt to check  
service users 
understanding but 
no/limited  answer to  
questions 
Good check of 
understanding and 
questions fully addressed 
Excellent check of 
understanding and questions 
fully addressed in a very 
positive manner   
  
4. Relevant incentive schedule clearly 
specified: 
 
 
 
a) Sessions 1-4: attendance and 
provision of a urine sample  
No schedule set out 
 
 
 
 
 
Schedule set out but 
limited link between 
incentive and 
  
 
attendance and 
provision of a urine 
sample 
Schedule clearly set out 
and clear explicit link made 
between incentive and 
 
 
attendance and provision 
of a urine sample 
Positive and encouraging 
manner. Schedule clearly set 
out and clear explicit link made 
between incentive and 
 
attendance and provision of a 
urine sample 
 
 
b) Sessions 5-12: attendance and 
provision of a negative urine sample  
 
 
 
 
attendance and 
provision of a negative 
urine sample  
 
 
 
 
 
 
 
 
attendance and provision 
of a negative urine sample  
 
 
attendance and provision of a 
negative urine sample  
 
 
 
 
 
 
 
  
Items 5, 6 and 7 to be completed when Incentive HAS been given 
5. Comments positively on clients 
attendance at correct time 
 
No comment on 
attendance at correct 
time- date or time 
Limited comment on 
attendance at correct 
time-specifying time  or 
date 
Clear comment on 
attendance at correct time 
AND date 
Clear and positive comment on 
attendance at correct time AND 
date 
6. Comments positively on clients 
 
a) Sessions 1-4 providing a urine 
sample 
No comment on providing  
a urine sample 
Limited comment on 
provision of required 
urine sample 
Clear comment on 
provision of required urine 
sample. Offers praise. 
Clear and positive comment on 
provision of urine sample.  
Offers praise and 
encouragement 
 
b) Sessions 5-12 providing a negative 
drug screening. 
 
No comment on providing  
a negative urine sample 
Limited comment on 
provision of a negative 
urine sample 
Clear comment on 
provision of a negative 
urine sample. Offers Praise 
Clear and positive comment on 
provision of a negative urine 
sample. Offers praise and 
encouragement 
 
7.Gives the incentive and clearly 
states in positive manner it is for 
attending on time and  
 
 
a) Sessions 1-4:provision of a urine 
Incentive not given 
 
Gives Incentive with 
limited comment on link 
to attendance or 
provision of 
 
Urine sample 
Gives incentive with clear 
comment on link to both 
attendance and 
 
Urine sample 
Gives incentive and offers 
praise with clear comment in a 
positive tone on link to both 
attendance and 
 
Urine sample 
  
sample     
 
b) Sessions 5-12: provision of a 
negative urine sample. 
  
Negative urine sample 
 
Negative urine sample 
 
Negative urine sample 
Items 8  and 9 to be completed when incentive HAS NOT been given 
8. Commented in a neutral manner 
on service user’s attendance at 
incorrect time and 
 
 
a) Sessions 1-4: failure to provide a 
urine sample 
 
Punitive tone with or 
without comment on 
service user attendance or  
 
 
failure to provide a urine 
sample 
 
Limited comment on 
service user attendance 
or 
 
 
failure to provide a 
urine sample 
 
Neutral tone. Clear 
comment on service user 
attendance AND 
 
 
failure to provide a urine 
sample 
 
Neutral tone. Comment to 
shape future behaviour. Clear 
comment on both service user 
attendance AND 
 
failure to provide a urine 
sample 
 
b) providing a positive urine sample providing  +ve urine  providing  +ve urine providing  +ve urine providing  +ve urine  
  
9) Withholds the incentive and 
clearly states  this is due to the client 
not attending  at the correct time or  
 
 
a) Sessions 1-4: failure to provide a 
urine sample  
 
Incentive given 
Or 
Punitive Tone. Incentive 
not given and no link to 
attendance or 
Failure to provide a urine 
sample 
Incentive not given with 
limited link to 
attendance OR 
 
 
Failure to provide a 
urine sample 
 
Incentive not given with 
clear comment on link to 
attendance AND 
 
 
Failure to provide a urine 
sample 
 
Incentive not given. Comment 
to shape future behaviour. Clear 
comment on link to attendance 
AND 
 
Failure to provide a urine 
sample 
b) Sessions 5-12: providing a positive 
urine sample. 
providing a +ve urine providing a +ve urine providing a +ve urine providing a +ve urine 
10. Agrees the day/date of the next 
test session 
 
No time given 
 
Time given and clearly 
specified 
 
Time given and clearly 
specified – importance of 
attendance emphasized 
Time given and clearly specified 
– importance of attendance and 
incentive emphasised in a 
positive manner  
 
  
Appendix E: Handbook for adherence measure for PRAISe 
contingency management program: Attendance and Abstinence 
versions 
 
 
  
Handbook for Adherence Measure for PRAISE contingency management 
program-Attendance 
In addition to individual training and supervision please use the descriptions below 
to aid judgments on adherence ratings. 
Item 1-Introduced self and put client at ease 
Poor –Key worker does not introduce themselves by name, does not mention clients 
name, or make general enquiry e.g. about wellbeing or recent activity in attempt to 
establish rapport and put client at ease 
Adequate- Therapist greets client offers some general inquiry to establish some 
rapport and put client at ease 
Good-Therapist clearly introduces themselves by name, specifies clients name. 
Makes some general enquiry to establish rapport or put client at ease. 
 Excellent-Therapist clearly introduces themselves by name, specifies clients name. 
Makes explicit general enquiry in attempt to establish rapport and out client at ease, 
appropriate follow up questions. Positive tone. 
 
Item 2- Described the purpose of the CM intervention 
Poor – No description of current session offered, no agenda set, no reference to 
contingency management or trial, or general aim to reduce illicit drug use 
Adequate- Comments that appointment involves using an incentive aiming to help 
reduce illicit drug use. 
  
Good-Comments that appointment is in addition to on-going  OST treatment which 
involves providing incentive aiming to help reduce illicit drug use. 
Excellent- Comments that appointment is in addition to on-going  OST treatment 
which involves providing incentive aiming to help reduce illicit drug use as part of a 
research trial. 
 
Item 3- Checked Service User Understanding 
Poor- No attempt to check understanding of CM intervention 
Adequate- Enquires about understanding and provided information but fails to 
address all questions fully 
Good- Enquire about understanding, provides relevant information and answers all 
questions 
Excellent- Enquires about understanding, provided relevant information, answers all 
questions and checks if questions have been answered satisfactorily. Positive and 
empathic stance. 
  
Item 4- relevant incentive schedule clearly specified 
Poor- No reference to incentive schedule. 
Adequate- Comments that an incentive is given for attendance. 
Good- Explains that incentive will be given for attending at agreed time. Describes 
incentive schedule i.e. £10 supermarket voucher for 12 weeks. 
  
Excellent- Explains incentive will be given for attending at agreed time (or within 15 
minute window immediately following agreed time). Describes incentive schedule 
i.e. £10 supermarket voucher for 12 weeks.  Describe purposes voucher can be put 
to. Make clear it will be given at beginning of session 
 
Item 5-  Comments positively on clients’ attendance at correct time  
Poor- No comment 
Adequate- Offers some comment on timely attendance. Specifies time or date. No 
explicit praise.  
Good- Clear comment on attendance at correct time, offers some praise. Specifies 
time and date. 
Excellent- Clear comment on attendance at correct time. Offers Praise and 
encouragement. Specified time and date 
 
Item 6- Give incentive and clearly states in a positive manner it is for attending 
on time 
Poor- Incentive not given 
Adequate- Gives incentive. Makes reference to timely attendance but does not make 
clear explicit link. 
Good-Gives incentive and makes a clear and explicit link to timely attendance. 
Offers some praise. 
  
Excellent- Give incentive and makes clear explicit link to timely attendance. Offers 
Praise and encouragement in a positive tone. 
Item 7- Commented in a neutral manner on service user’s attendance at 
incorrect time 
Poor- Talks in a punitive tone. Irrespective of whether therapist comments on 
attendance using a punitive tone scores 0. 
Adequate- Makes some comment on client attending at incorrect time . Is not 
punitive. 
Good.-Makes clear explicit comment on attending at incorrect time in a neutral tone. 
Excellent-Makes clear explicit comment on attending at incorrect time in a neutral 
tone. Praises attendance and encourages future attendance to be on time in effort to 
shape future behaviour. 
Item 9- Withholds incentive and clearly states this is due to the client not 
attending at correct time  
Poor- Therapist mistakenly gives incentive OR Uses a punitive tone  OR Incentive is 
not given but no link is made to attendance 
Adequate.- Incentive is not given. Makes reference to attendance but does not make 
clear explicit link 
Good-Incentive not given, makes clear explicit link between lack of incentive and 
attendance 
  
Excellent- Incentive not given,  clear explicit link between lack of incentive and  
attendance . Praises attendance and encourage future attendance to be on time in 
effort to shape future behaviour. 
Item 10-Agress time and date of next session. See measure, nothing to elaborate 
on. 
  
Handbook for Adherence Measure for PRAISE contingency management 
program Abstinence 
In addition to individual training and supervision please use the descriptions below 
to aid judgments on adherence ratings. 
Item 1-Introduced self and put client at ease 
Poor –Key worker does not introduce themselves by name, does not mention clients 
name, or comment enquire about wellbeing or recent activity in attempt to establish 
rapport and put client at ease 
Adequate- Therapist greets client offers some general inquiry to establish some 
rapport and put client at ease 
Good-Therapist clearly introduces themselves by name, specifies clients name. 
Makes some general enquiry to establish rapport or put client at ease. 
 Excellent-Therapist clearly introduces themselves by name, specifies clients name. 
Makes explicit general enquiry in attempt to establish rapport and out client at ease, 
appropriate follow up questions. Positive tone 
 
Item 2- Described the purpose of the CM intervention 
Poor – No description of current session offered, no agenda set, no reference to 
contingency management or trial or general aim to reduce illicit drug use 
Adequate- - Comments that appointment involves using an incentive aiming to help 
reduce illicit drug use. 
  
Good-Comments that appointment is in addition of on-going  OST treatment which 
involves providing incentive aiming to help reduce illicit drug use. 
Excellent- Comments that appointment is in addition to on-going  OST treatment 
which involves providing incentive aiming to help reduce illicit drug use as part of a 
research trial. 
 
Item 3- Checked Service User Understanding 
Poor- No attempt to check understanding 
Adequate- Enquires about understanding and provided information but fails to 
address all questions fully 
Good- Enquire about understanding, provides relevant information and answers all 
questions 
Excellent- Enquires about understanding, provided relevant information, answers all 
questions and checks if questions have been answered satisfactorily. Positive and 
empathic stance 
 
Item 4- relevant incentive schedule clearly specified 
Poor- No reference to incentive schedule. 
Adequate- Comments that an incentive is given for attendance/provision of urine. 
Good- Explains that incentive will be given for attending at agreed time AND 
providing urine (makes distinction about first 4 weeks and subsequent weeks i.e. 
  
incentive is not contingent on a negative urine sample in first 4 weeks). Describes 
incentive schedule i.e. £10 supermarket voucher for 12 weeks. 
Excellent- Explains incentive will be given for attending at agreed time and provision 
of urine (or within 15 minute window immediately following agreed time). Makes 
distinction about first 4 weeks and subsequent weeks. Describes incentive schedule 
i.e. £10 supermarket voucher for 12 weeks.  Describe purposes voucher can be put 
to. Make clear it will be given at beginning of session 
 
Item 5-  Comments positively on clients’ attendance at correct time  
Poor- No comment 
Adequate- Offers some comment on timely attendance. Specifies time or date. No 
explicit praise.  
Good- Clear comment on attendance at correct time, offers some praise. Specifies 
time and date. 
Excellent- Clear comment on attendance at correct time. Offers Praise and 
encouragement. Specified time and date 
 
Item 6- Comments positively on: 
Sessions1-4;  clients provision of a urine test  
Sessions 5-12; client’s provision of –ve urine test 
Poor- No comment 
  
Adequate- Offers some comment on provision of urine sample but does not explicitly 
praise.  
Good- Clear comment on provision of urine sample, offers some praise 
Excellent- Clear comment on provision of urine sample. Offers praise and 
encouragement in a positive tone. 
 
Item 7- Give incentive and clearly states in a positive manner it is for attending 
on time and urine sample 
Poor- Incentive not given 
Adequate- Gives incentive. Makes reference to timely attendance or urine test but 
does not make clear explicit link. 
Good-Gives incentive and makes a clear and explicit link to timely attendance and 
urine sample. Offers some praise. 
Excellent- Give incentive and makes clear explicit link to timely attendance and 
urine sample. Offers praise and encouragement in a positive tone. 
Item 8- Commented in a neutral manner on service user’s attendance at 
incorrect time and urine sample 
Poor- Talks in a punitive tone. Irrespective of whether therapist comments on 
attendance or urine sample, using a punitive tone scores 0 
Adequate- Makes some comment on client attending at incorrect time or urine 
sample. Is not punitive but does not explicitly mention both. 
  
Good.-Makes clear explicit comment about attendance and urine sample in a neutral 
tone. 
Excellent-makes clear explicit comment on both attendance and urine sample in a 
neutral tone. Praises target behaviour met, or attendance at incorrect time, and 
encourage future target behaviours in an effort to shape behaviour.  
Item 9- Withholds incentive and clearly states this is due to the client not 
attending at correct time or urine sample 
Poor- Therapist mistakenly gives incentive OR Uses a punitive tone  OR Incentive is 
not given but no link is made to attendance or urine sample. 
Adequate.- Incentive is not given. Makes reference to attendance or urine sample but 
does not make clear explicit link 
Good-Incentive not given, makes clear explicit link between lack of incentive and 
relevant  target behaviour (or both). 
Excellent- Incentive not given,  clear explicit link between lack of incentive and 
target behaviour. Comments on target behaviour that was successful if appropriate 
and emphasises importance of target behaviours and link to future incentive. 
Item 10-Agress time and date of next session. See measure, nothing to elaborate 
on 
 
  
 
